ONTOLOGY REPORT - ANNOTATIONS
|
||||||||||||||||||||||||||||
pirinixic acid
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | A1BG | alpha-1-B glycoprotein |
|
increases expression | ISO | 19 | 58,858,172 | 58,864,865 | RGD:6480464 | CTD | |
| G | A2M | alpha-2-macroglobulin |
|
decreases expression | ISO | 12 | 9,220,304 | 9,268,558 | RGD:6480464 | CTD | |
| G | A2M | alpha-2-macroglobulin |
|
multiple interactions | ISO | 12 | 9,220,304 | 9,268,558 | RGD:6480464 | CTD | |
| G | AAAS | achalasia, adrenocortical insufficiency, alacrimia |
|
multiple interactions | EXP | 12 | 53,701,240 | 53,715,412 | RGD:6480464 | CTD | |
| G | AACS | acetoacetyl-CoA synthetase |
|
decreases expression | ISO | 12 | 125,549,925 | 125,627,871 | RGD:6480464 | CTD | |
| G | AACS | acetoacetyl-CoA synthetase |
|
increases expression | ISO | 12 | 125,549,925 | 125,627,871 | RGD:6480464 | CTD | |
| G | AADAC | arylacetamide deacetylase |
|
multiple interactions | EXP | 3 | 151,531,861 | 151,546,276 | RGD:6480464 | CTD | |
| G | AADAC | arylacetamide deacetylase |
|
increases expression | ISO | 3 | 151,531,861 | 151,546,276 | RGD:6480464 | CTD | |
| G | AARS | alanyl-tRNA synthetase |
|
affects expression | ISO | 16 | 70,286,297 | 70,323,412 | RGD:6480464 | CTD | |
| G | AASDHPPT | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase |
|
increases expression | ISO | 11 | 105,948,292 | 105,969,419 | RGD:6480464 | CTD | |
| G | AASS | aminoadipate-semialdehyde synthase |
|
increases expression | ISO | 7 | 121,713,598 | 121,784,344 | RGD:6480464 | CTD | |
| G | ABAT | 4-aminobutyrate aminotransferase |
|
multiple interactions | EXP | 16 | 8,768,444 | 8,878,432 | RGD:6480464 | CTD | |
| G | ABAT | 4-aminobutyrate aminotransferase |
|
decreases expression | ISO | 16 | 8,768,444 | 8,878,432 | RGD:6480464 | CTD | |
| G | ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 |
|
increases expression | ISO | 9 | 107,543,283 | 107,690,527 | RGD:6480464 | CTD | |
| G | ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 |
|
multiple interactions | ISO | 9 | 107,543,283 | 107,690,527 | RGD:6480464 | CTD | |
| G | ABCA17P | ATP-binding cassette, sub-family A (ABC1), member 17, pseudogene |
|
increases expression | ISO | 16 | 2,390,923 | 2,476,700 | RGD:6480464 | CTD | |
| G | ABCA4 | ATP-binding cassette, sub-family A (ABC1), member 4 |
|
increases expression | ISO | 1 | 94,458,393 | 94,586,705 | RGD:6480464 | CTD | |
| G | ABCA4 | ATP-binding cassette, sub-family A (ABC1), member 4 |
|
multiple interactions | ISO | 1 | 94,458,393 | 94,586,705 | RGD:6480464 | CTD | |
| G | ABCA7 | ATP-binding cassette, sub-family A (ABC1), member 7 |
|
decreases expression | ISO | 19 | 1,040,102 | 1,065,571 | RGD:6480464 | CTD | |
| G | ABCA8 | ATP-binding cassette, sub-family A (ABC1), member 8 |
|
multiple interactions | ISO | 17 | 66,863,430 | 66,951,533 | RGD:6480464 | CTD | |
| G | ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
|
multiple interactions | EXP | 7 | 87,133,179 | 87,342,639 | RGD:6480464 | CTD | |
| G | ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 |
|
decreases activity | EXP | 2 | 169,779,449 | 169,887,833 | RGD:6480464 | CTD | |
| G | ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 |
|
multiple interactions | ISO | 2 | 169,779,449 | 169,887,833 | RGD:6480464 | CTD | |
| G | ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 |
|
decreases expression | ISO | 2 | 169,779,449 | 169,887,833 | RGD:6480464 | CTD | |
| G | ABCB4 | ATP-binding cassette, sub-family B (MDR/TAP), member 4 |
|
increases expression | ISO | 7 | 87,031,361 | 87,105,019 | RGD:6480464 | CTD | |
| G | ABCB6 | ATP-binding cassette, sub-family B (MDR/TAP), member 6 |
|
increases expression | ISO | 2 | 220,074,488 | 220,083,712 | RGD:6480464 | CTD | |
| G | ABCB8 | ATP-binding cassette, sub-family B (MDR/TAP), member 8 |
|
increases expression | ISO | 7 | 150,725,510 | 150,744,869 | RGD:6480464 | CTD | |
| G | ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
|
multiple interactions | EXP | 10 | 101,542,463 | 101,611,662 | RGD:6480464 | CTD | |
| G | ABCC3 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
|
multiple interactions | EXP | 17 | 48,712,218 | 48,769,063 | RGD:6480464 | CTD | |
| G | ACYP2 | acylphosphatase 2, muscle type |
|
increases expression | ISO | 2 | 54,342,410 | 54,532,437 | RGD:6480464 | CTD | |
| G | ANKHD1 | ankyrin repeat and KH domain containing 1 |
|
decreases expression | ISO | 5 | 139,781,399 | 139,919,441 | RGD:6480464 | CTD | |
| G | ANKMY1 | ankyrin repeat and MYND domain containing 1 |
|
increases expression | ISO | 2 | 241,418,839 | 241,497,405 | RGD:6480464 | CTD | |
| G | ANTXR2 | anthrax toxin receptor 2 |
|
decreases expression | ISO | 4 | 80,822,771 | 80,994,477 | RGD:6480464 | CTD | |
| G | APOL3 | apolipoprotein L, 3 |
|
decreases expression | ISO | 22 | 36,536,371 | 36,562,225 | RGD:6480464 | CTD | |
| G | ARHGEF38 | Rho guanine nucleotide exchange factor (GEF) 38 |
|
multiple interactions | ISO | 4 | 106,473,777 | 106,602,070 | RGD:6480464 | CTD | |
| G | CBX3 | chromobox homolog 3 |
|
decreases expression | ISO | 7 | 26,240,831 | 26,253,227 | RGD:6480464 | CTD | |
| G | CCDC83 | coiled-coil domain containing 83 |
|
increases expression | ISO | 11 | 85,566,144 | 85,631,051 | RGD:6480464 | CTD | |
| G | CDK4 | cyclin-dependent kinase 4 |
|
increases expression | ISO | 12 | 58,141,510 | 58,146,230 | RGD:6480464 | CTD | |
| G | CDSN | corneodesmosin |
|
multiple interactions | ISO | 6 | 31,082,865 | 31,088,252 | RGD:6480464 | CTD | |
| G | CKMT2 | creatine kinase, mitochondrial 2 (sarcomeric) |
|
increases expression | ISO | 5 | 80,529,139 | 80,562,217 | RGD:6480464 | CTD | |
| G | CR1L | complement component (3b/4b) receptor 1-like |
|
increases expression | ISO | 1 | 207,818,458 | 207,897,036 | RGD:6480464 | CTD | |
| G | CYP2A13 | cytochrome P450, family 2, subfamily A, polypeptide 13 |
|
decreases expression | ISO | 19 | 41,594,356 | 41,602,100 | RGD:6480464 | CTD | |
| G | CYP2A13 | cytochrome P450, family 2, subfamily A, polypeptide 13 |
|
affects expression | ISO | 19 | 41,594,356 | 41,602,100 | RGD:6480464 | CTD | |
| G | CYP2C18 | cytochrome P450, family 2, subfamily C, polypeptide 18 |
|
multiple interactions | ISO | 10 | 96,443,251 | 96,495,947 | RGD:6480464 | CTD | |
| G | CYP2C18 | cytochrome P450, family 2, subfamily C, polypeptide 18 |
|
decreases expression | ISO | 10 | 96,443,251 | 96,495,947 | RGD:6480464 | CTD | |
| G | CYP2C19 | cytochrome P450, family 2, subfamily C, polypeptide 19 |
|
multiple interactions | ISO | 10 | 96,522,463 | 96,612,671 | RGD:6480464 | CTD | |
| G | CYP2C19 | cytochrome P450, family 2, subfamily C, polypeptide 19 |
|
increases expression | ISO | 10 | 96,522,463 | 96,612,671 | RGD:6480464 | CTD | |
| G | CYP2C19 | cytochrome P450, family 2, subfamily C, polypeptide 19 |
|
multiple interactions | ISO | 10 | 96,522,463 | 96,612,671 | RGD:6480464 | CTD | |
| G | CYP2C9 | cytochrome P450, family 2, subfamily C, polypeptide 9 |
|
decreases expression | ISO | 10 | 96,698,415 | 96,749,148 | RGD:6480464 | CTD | |
| G | CYP2C9 | cytochrome P450, family 2, subfamily C, polypeptide 9 |
|
decreases expression | ISO | 10 | 96,698,415 | 96,749,148 | RGD:6480464 | CTD | |
| G | CYP2D6 | cytochrome P450, family 2, subfamily D, polypeptide 6 |
|
affects expression | ISO | 22 | 42,522,501 | 42,526,883 | RGD:6480464 | CTD | |
| G | CYP4F3 | cytochrome P450, family 4, subfamily F, polypeptide 3 |
|
increases expression | ISO | 19 | 15,751,707 | 15,771,570 | RGD:6480464 | CTD | |
| G | CYP4F3 | cytochrome P450, family 4, subfamily F, polypeptide 3 |
|
affects expression | ISO | 19 | 15,751,707 | 15,771,570 | RGD:6480464 | CTD | |
| G | CYP4F3 | cytochrome P450, family 4, subfamily F, polypeptide 3 |
|
decreases expression | ISO | 19 | 15,751,707 | 15,771,570 | RGD:6480464 | CTD | |
| G | CYP4F8 | cytochrome P450, family 4, subfamily F, polypeptide 8 |
|
multiple interactions | ISO | 19 | 15,726,029 | 15,740,448 | RGD:6480464 | CTD | |
| G | CYP4F8 | cytochrome P450, family 4, subfamily F, polypeptide 8 |
|
decreases expression | ISO | 19 | 15,726,029 | 15,740,448 | RGD:6480464 | CTD | |
| G | CYP4F8 | cytochrome P450, family 4, subfamily F, polypeptide 8 |
|
increases expression | ISO | 19 | 15,726,029 | 15,740,448 | RGD:6480464 | CTD | |
| G | CYP4F8 | cytochrome P450, family 4, subfamily F, polypeptide 8 |
|
decreases expression | ISO | 19 | 15,726,029 | 15,740,448 | RGD:6480464 | CTD | |
| G | DCAF12L1 | DDB1 and CUL4 associated factor 12-like 1 |
|
increases expression | ISO | X | 125,683,366 | 125,686,842 | RGD:6480464 | CTD | |
| G | DCDC2C | doublecortin domain containing 2C |
|
multiple interactions | ISO | 2 | 3,751,188 | 3,895,001 | RGD:6480464 | CTD | |
| G | DCDC2C | doublecortin domain containing 2C |
|
increases expression | ISO | 2 | 3,751,188 | 3,895,001 | RGD:6480464 | CTD | |
| G | DEXI | Dexi homolog (mouse) |
|
affects expression | ISO | 16 | 11,022,748 | 11,036,257 | RGD:6480464 | CTD | |
| G | DMPK | dystrophia myotonica-protein kinase |
|
increases expression | ISO | 19 | 46,272,975 | 46,285,815 | RGD:6480464 | CTD | |
| G | DNAJC19 | DnaJ (Hsp40) homolog, subfamily C, member 19 |
|
increases expression | ISO | 3 | 180,701,497 | 180,707,562 | RGD:6480464 | CTD | |
| G | EIF1 | eukaryotic translation initiation factor 1 |
|
increases expression | ISO | 17 | 39,845,127 | 39,847,898 | RGD:6480464 | CTD | |
| G | ENHO | energy homeostasis associated |
|
increases expression | ISO | 9 | 34,521,040 | 34,523,037 | RGD:6480464 | CTD | |
| G | ENPEP | glutamyl aminopeptidase (aminopeptidase A) |
|
affects expression | ISO | 4 | 111,397,229 | 111,484,493 | RGD:6480464 | CTD | |
| G | FAM181A | family with sequence similarity 181, member A |
|
multiple interactions | ISO | 14 | 94,385,240 | 94,395,954 | RGD:6480464 | CTD | |
| G | FAM25C | family with sequence similarity 25, member C |
|
multiple interactions | ISO | 10 | 49,203,372 | 49,207,825 | RGD:6480464 | CTD | |
| G | FAM25C | family with sequence similarity 25, member C |
|
decreases expression | ISO | 10 | 49,203,372 | 49,207,825 | RGD:6480464 | CTD | |
| G | FCGBP | Fc fragment of IgG binding protein |
|
increases expression | ISO | 19 | 40,353,963 | 40,440,533 | RGD:6480464 | CTD | |
| G | FN3K | fructosamine 3 kinase |
|
decreases expression | ISO | 17 | 80,693,452 | 80,709,073 | RGD:6480464 | CTD | |
| G | FOXC2 | forkhead box C2 (MFH-1, mesenchyme forkhead 1) |
|
increases expression | ISO | 16 | 86,600,857 | 86,602,539 | RGD:6480464 | CTD | |
| G | GGACT | gamma-glutamylamine cyclotransferase |
|
decreases expression | ISO | 13 | 101,182,418 | 101,241,046 | RGD:6480464 | CTD | |
| G | GRAMD1C | GRAM domain containing 1C |
|
multiple interactions | ISO | 3 | 113,557,681 | 113,666,021 | RGD:6480464 | CTD | |
| G | GSTA5 | glutathione S-transferase alpha 5 |
|
increases expression | ISO | 6 | 52,696,540 | 52,710,893 | RGD:6480464 | CTD | |
| G | HDDC3 | HD domain containing 3 |
|
increases expression | ISO | 15 | 91,474,155 | 91,475,774 | RGD:6480464 | CTD | |
| G | HIGD1A | HIG1 hypoxia inducible domain family, member 1A |
|
increases expression | ISO | 3 | 42,824,400 | 42,846,027 | RGD:6480464 | CTD | |
| G | HIST1H2BO | histone cluster 1, H2bo |
|
decreases expression | ISO | 6 | 27,861,203 | 27,861,669 | RGD:6480464 | CTD | |
| G | HK3 | hexokinase 3 (white cell) |
|
increases expression | ISO | 5 | 176,307,870 | 176,326,333 | RGD:6480464 | CTD | |
| G | HLA-C | major histocompatibility complex, class I, C |
|
decreases expression | ISO | 6 | 31,236,526 | 31,239,913 | RGD:6480464 | CTD | |
| G | HLA-DMA | major histocompatibility complex, class II, DM alpha |
|
decreases expression | ISO | 6 | 32,916,391 | 32,920,899 | RGD:6480464 | CTD | |
| G | HLA-DRA | major histocompatibility complex, class II, DR alpha |
|
decreases expression | ISO | 6 | 32,407,619 | 32,412,823 | RGD:6480464 | CTD | |
| G | HLA-DRA | major histocompatibility complex, class II, DR alpha |
|
multiple interactions | EXP | 6 | 32,407,619 | 32,412,823 | RGD:6480464 | CTD | |
| G | HLCS | holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase) |
|
multiple interactions | ISO | 21 | 38,123,189 | 38,362,545 | RGD:6480464 | CTD | |
| G | HLF | hepatic leukemia factor |
|
increases expression | ISO | 17 | 53,342,321 | 53,402,426 | RGD:6480464 | CTD | |
| G | HLTF | helicase-like transcription factor |
|
decreases expression | ISO | 3 | 148,747,904 | 148,804,341 | RGD:6480464 | CTD | |
| G | HLX | H2.0-like homeobox |
|
multiple interactions | EXP | 1 | 221,052,743 | 221,058,401 | RGD:6480464 | CTD | |
| G | HM13 | histocompatibility (minor) 13 |
|
multiple interactions | EXP | 20 | 30,102,241 | 30,157,370 | RGD:6480464 | CTD | |
| G | HMBS | hydroxymethylbilane synthase |
|
increases expression | ISO | 11 | 118,955,587 | 118,964,259 | RGD:6480464 | CTD | |
| G | HMG20A | high mobility group 20A |
|
multiple interactions | ISO | 15 | 77,713,243 | 77,777,945 | RGD:6480464 | CTD | |
| G | HMGA2 | high mobility group AT-hook 2 |
|
increases expression | ISO | 12 | 66,218,240 | 66,360,071 | RGD:6480464 | CTD | |
| G | HMGB2 | high mobility group box 2 |
|
increases expression | ISO | 4 | 174,252,527 | 174,255,595 | RGD:6480464 | CTD | |
| G | HMGB2 | high mobility group box 2 |
|
increases expression | ISO | 4 | 174,252,527 | 174,255,595 | RGD:6480464 | CTD | |
| G | HMGB3 | high mobility group box 3 |
|
increases expression | ISO | X | 150,151,763 | 150,159,248 | RGD:6480464 | CTD | |
| G | HMGCL | 3-hydroxymethyl-3-methylglutaryl-CoA lyase |
|
increases expression | ISO | 1 | 24,128,367 | 24,151,949 | RGD:6480464 | CTD | |
| G | HMGCL | 3-hydroxymethyl-3-methylglutaryl-CoA lyase |
|
multiple interactions | ISO | 1 | 24,128,367 | 24,151,949 | RGD:6480464 | CTD | |
| G | HMGCL | 3-hydroxymethyl-3-methylglutaryl-CoA lyase |
|
increases expression | ISO | 1 | 24,128,367 | 24,151,949 | RGD:6480464 | CTD | |
| G | HMGCR | 3-hydroxy-3-methylglutaryl-CoA reductase |
|
multiple interactions | ISO | 5 | 74,632,993 | 74,657,926 | RGD:6480464 | CTD | |
| G | HMGCR | 3-hydroxy-3-methylglutaryl-CoA reductase |
|
decreases expression | ISO | 5 | 74,632,993 | 74,657,926 | RGD:6480464 | CTD | |
| G | HMGCR | 3-hydroxy-3-methylglutaryl-CoA reductase |
|
decreases expression | ISO | 5 | 74,632,993 | 74,657,926 | RGD:6480464 | CTD | |
| G | HMGCS1 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
|
decreases expression | ISO | 5 | 43,287,572 | 43,313,614 | RGD:6480464 | CTD | |
| G | HMGCS1 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
|
increases expression | ISO | 5 | 43,287,572 | 43,313,614 | RGD:6480464 | CTD | |
| G | HMGCS1 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
|
multiple interactions | ISO | 5 | 43,287,572 | 43,313,614 | RGD:6480464 | CTD | |
| G | HMGCS1 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
|
increases expression | ISO | 5 | 43,287,572 | 43,313,614 | RGD:6480464 | CTD | |
| G | HPS5 | Hermansky-Pudlak syndrome 5 |
|
affects expression | ISO | 11 | 18,300,217 | 18,343,721 | RGD:6480464 | CTD | |
| G | HRK | harakiri, BCL2 interacting protein (contains only BH3 domain) |
|
increases expression | ISO | 12 | 117,299,027 | 117,319,232 | RGD:6480464 | CTD | |
| G | HRSP12 | heat-responsive protein 12 |
|
affects expression | ISO | 8 | 99,114,567 | 99,129,418 | RGD:6480464 | CTD | |
| G | HRSP12 | heat-responsive protein 12 |
|
decreases expression | ISO | 8 | 99,114,567 | 99,129,418 | RGD:6480464 | CTD | |
| G | HS3ST5 | heparan sulfate (glucosamine) 3-O-sulfotransferase 5 |
|
multiple interactions | ISO | 6 | 114,376,750 | 114,384,041 | RGD:6480464 | CTD | |
| G | HS6ST1 | heparan sulfate 6-O-sulfotransferase 1 |
|
increases expression | ISO | 2 | 129,023,054 | 129,076,171 | RGD:6480464 | CTD | |
| G | HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 |
|
multiple interactions | ISO | 1 | 209,859,525 | 209,908,295 | RGD:6480464 | CTD | |
| G | HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 |
|
decreases expression | ISO | 1 | 209,859,525 | 209,908,295 | RGD:6480464 | CTD | |
| G | HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 |
|
multiple interactions | ISO | 1 | 209,859,525 | 209,908,295 | RGD:6480464 | CTD | |
| G | HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 |
|
decreases expression | ISO | 1 | 209,859,525 | 209,908,295 | RGD:6480464 | CTD | |
| G | HSD17B10 | hydroxysteroid (17-beta) dehydrogenase 10 |
|
multiple interactions | ISO | X | 53,458,206 | 53,461,323 | RGD:6480464 | CTD | |
| G | HSD17B10 | hydroxysteroid (17-beta) dehydrogenase 10 |
|
increases expression | ISO | X | 53,458,206 | 53,461,323 | RGD:6480464 | CTD | |
| G | HSD17B11 | hydroxysteroid (17-beta) dehydrogenase 11 |
|
multiple interactions | ISO | 4 | 88,257,691 | 88,312,455 | RGD:6480464 | CTD | |
| G | HSD17B11 | hydroxysteroid (17-beta) dehydrogenase 11 |
|
increases expression | ISO | 4 | 88,257,691 | 88,312,455 | RGD:6480464 | CTD | |
| G | HSD17B12 | hydroxysteroid (17-beta) dehydrogenase 12 |
|
increases expression | ISO | 11 | 43,702,143 | 43,878,169 | RGD:6480464 | CTD | |
| G | HSD17B12 | hydroxysteroid (17-beta) dehydrogenase 12 |
|
multiple interactions | ISO | 11 | 43,702,143 | 43,878,169 | RGD:6480464 | CTD | |
| G | HSD17B12 | hydroxysteroid (17-beta) dehydrogenase 12 |
|
increases expression | ISO | 11 | 43,702,143 | 43,878,169 | RGD:6480464 | CTD | |
| G | HSD17B13 | hydroxysteroid (17-beta) dehydrogenase 13 |
|
increases expression | ISO | 4 | 88,224,941 | 88,244,056 | RGD:6480464 | CTD | |
| G | HSD17B2 | hydroxysteroid (17-beta) dehydrogenase 2 |
|
decreases expression | ISO | 16 | 82,068,858 | 82,132,139 | RGD:6480464 | CTD | |
| G | HSD17B2 | hydroxysteroid (17-beta) dehydrogenase 2 |
|
increases expression | ISO | 16 | 82,068,858 | 82,132,139 | RGD:6480464 | CTD | |
| G | HSD17B4 | hydroxysteroid (17-beta) dehydrogenase 4 |
|
increases expression | ISO | 5 | 118,788,138 | 118,878,030 | RGD:6480464 | CTD | |
| G | HSD17B4 | hydroxysteroid (17-beta) dehydrogenase 4 |
|
multiple interactions | ISO | 5 | 118,788,138 | 118,878,030 | RGD:6480464 | CTD | |
| G | HSD17B4 | hydroxysteroid (17-beta) dehydrogenase 4 |
|
multiple interactions | ISO | 5 | 118,788,138 | 118,878,030 | RGD:6480464 | CTD | |
| G | HSD17B4 | hydroxysteroid (17-beta) dehydrogenase 4 |
|
multiple interactions | ISO | 5 | 118,788,138 | 118,878,030 | RGD:6480464 | CTD | |
| G | HSD17B4 | hydroxysteroid (17-beta) dehydrogenase 4 |
|
affects expression | ISO | 5 | 118,788,138 | 118,878,030 | RGD:6480464 | CTD | |
| G | HSD17B4 | hydroxysteroid (17-beta) dehydrogenase 4 |
|
increases expression | ISO | 5 | 118,788,138 | 118,878,030 | RGD:6480464 | CTD | |
| G | HSD17B7 | hydroxysteroid (17-beta) dehydrogenase 7 |
|
increases expression | ISO | 1 | 162,760,496 | 162,782,608 | RGD:6480464 | CTD | |
| G | HSD3B1 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
|
multiple interactions | ISO | 1 | 120,049,826 | 120,057,681 | RGD:6480464 | CTD | |
| G | HSD3B2 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
|
multiple interactions | ISO | 1 | 119,957,554 | 119,965,662 | RGD:6480464 | CTD | |
| G | HSD3B2 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
|
decreases expression | ISO | 1 | 119,957,554 | 119,965,662 | RGD:6480464 | CTD | |
| G | HSD3B2 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
|
multiple interactions | ISO | 1 | 119,957,554 | 119,965,662 | RGD:6480464 | CTD | |
| G | HSD3B7 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
|
decreases expression | ISO | 16 | 30,996,519 | 31,000,473 | RGD:6480464 | CTD | |
| G | HSDL2 | hydroxysteroid dehydrogenase like 2 |
|
increases expression | ISO | 9 | 115,142,189 | 115,234,685 | RGD:6480464 | CTD | |
| G | HSDL2 | hydroxysteroid dehydrogenase like 2 |
|
affects expression | ISO | 9 | 115,142,189 | 115,234,685 | RGD:6480464 | CTD | |
| G | HSF1 | heat shock transcription factor 1 |
|
increases expression | ISO | 8 | 145,515,270 | 145,538,385 | RGD:6480464 | CTD | |
| G | HSF1 | heat shock transcription factor 1 |
|
increases expression | ISO | 8 | 145,515,270 | 145,538,385 | RGD:6480464 | CTD | |
| G | HSF5 | heat shock transcription factor family member 5 |
|
increases expression | ISO | 17 | 56,497,529 | 56,565,759 | RGD:6480464 | CTD | |
| G | HSP90AA1 | heat shock protein 90kDa alpha (cytosolic), class A member 1 |
|
increases expression | ISO | 14 | 102,547,075 | 102,606,086 | RGD:6480464 | CTD | |
| G | HSP90AA1 | heat shock protein 90kDa alpha (cytosolic), class A member 1 |
|
increases expression | ISO | 14 | 102,547,075 | 102,606,086 | RGD:6480464 | CTD | |
| G | HSP90AA1 | heat shock protein 90kDa alpha (cytosolic), class A member 1 |
|
multiple interactions | ISO | 14 | 102,547,075 | 102,606,086 | RGD:6480464 | CTD | |
| G | HSP90AA1 | heat shock protein 90kDa alpha (cytosolic), class A member 1 |
|
increases expression | ISO | 14 | 102,547,075 | 102,606,086 | RGD:6480464 | CTD | |
| G | HSP90AB1 | heat shock protein 90kDa alpha (cytosolic), class B member 1 |
|
increases expression | ISO | 6 | 44,214,849 | 44,221,614 | RGD:6480464 | CTD | |
| G | HSPA12A | heat shock 70kDa protein 12A |
|
decreases expression | ISO | 10 | 118,430,703 | 118,502,085 | RGD:6480464 | CTD | |
| G | HSPA14 | heat shock 70kDa protein 14 |
|
multiple interactions | ISO | 10 | 14,880,261 | 14,913,740 | RGD:6480464 | CTD | |
| G | HSPA14 | heat shock 70kDa protein 14 |
|
increases expression | ISO | 10 | 14,880,261 | 14,913,740 | RGD:6480464 | CTD | |
| G | HSPA1A | heat shock 70kDa protein 1A |
|
multiple interactions | ISO | 6 | 31,783,291 | 31,785,719 | RGD:6480464 | CTD | |
| G | HSPA1A | heat shock 70kDa protein 1A |
|
decreases expression | ISO | 6 | 31,783,291 | 31,785,719 | RGD:6480464 | CTD | |
| G | HSPE1 | heat shock 10kDa protein 1 (chaperonin 10) |
|
decreases expression | ISO | 2 | 198,364,721 | 198,368,187 | RGD:6480464 | CTD | |
| G | HSPE1 | heat shock 10kDa protein 1 (chaperonin 10) |
|
increases expression | ISO | 2 | 198,364,721 | 198,368,187 | RGD:6480464 | CTD | |
| G | ICOS | inducible T-cell co-stimulator |
|
decreases expression | ISO | 2 | 204,801,471 | 204,826,300 | RGD:6480464 | CTD | |
| G | ICOS | inducible T-cell co-stimulator |
|
multiple interactions | ISO | 2 | 204,801,471 | 204,826,300 | RGD:6480464 | CTD | |
| G | IER5 | immediate early response 5 |
|
decreases expression | ISO | 1 | 181,057,638 | 181,059,979 | RGD:6480464 | CTD | |
| G | IER5L | immediate early response 5-like |
|
decreases expression | ISO | 9 | 131,937,831 | 131,940,540 | RGD:6480464 | CTD | |
| G | IFFO1 | intermediate filament family orphan 1 |
|
decreases expression | ISO | 12 | 6,648,694 | 6,665,249 | RGD:6480464 | CTD | |
| G | IFFO1 | intermediate filament family orphan 1 |
|
increases expression | ISO | 12 | 6,648,694 | 6,665,249 | RGD:6480464 | CTD | |
| G | IFFO2 | intermediate filament family orphan 2 |
|
multiple interactions | EXP | 1 | 19,230,774 | 19,282,826 | RGD:6480464 | CTD | |
| G | IFI16 | interferon, gamma-inducible protein 16 |
|
decreases expression | ISO | 1 | 158,979,682 | 159,024,945 | RGD:6480464 | CTD | |
| G | IFI27 | interferon, alpha-inducible protein 27 |
|
multiple interactions | ISO | 14 | 94,577,079 | 94,583,033 | RGD:6480464 | CTD | |
| G | IFI27 | interferon, alpha-inducible protein 27 |
|
decreases expression | ISO | 14 | 94,577,079 | 94,583,033 | RGD:6480464 | CTD | |
| G | IFI27 | interferon, alpha-inducible protein 27 |
|
multiple interactions | ISO | 14 | 94,577,079 | 94,583,033 | RGD:6480464 | CTD | |
| G | IFI27 | interferon, alpha-inducible protein 27 |
|
decreases expression | ISO | 14 | 94,577,079 | 94,583,033 | RGD:6480464 | CTD | |
| G | IFIH1 | interferon induced with helicase C domain 1 |
|
decreases expression | ISO | 2 | 163,123,589 | 163,175,218 | RGD:6480464 | CTD | |
| G | IFIT1 | interferon-induced protein with tetratricopeptide repeats 1 |
|
multiple interactions | EXP | 10 | 91,152,303 | 91,166,244 | RGD:6480464 | CTD | |
| G | IFIT2 | interferon-induced protein with tetratricopeptide repeats 2 |
|
multiple interactions | EXP | 10 | 91,061,706 | 91,069,033 | RGD:6480464 | CTD | |
| G | IFIT3 | interferon-induced protein with tetratricopeptide repeats 3 |
|
increases expression | ISO | 10 | 91,087,602 | 91,100,725 | RGD:6480464 | CTD | |
| G | IFIT3 | interferon-induced protein with tetratricopeptide repeats 3 |
|
increases expression | ISO | 10 | 91,087,602 | 91,100,725 | RGD:6480464 | CTD | |
| G | IFITM2 | interferon induced transmembrane protein 2 |
|
multiple interactions | EXP | 11 | 308,107 | 309,410 | RGD:6480464 | CTD | |
| G | IFITM3 | interferon induced transmembrane protein 3 |
|
decreases expression | ISO | 11 | 319,673 | 320,914 | RGD:6480464 | CTD | |
| G | IFITM3 | interferon induced transmembrane protein 3 |
|
multiple interactions | ISO | 11 | 319,673 | 320,914 | RGD:6480464 | CTD | |
| G | IFITM3 | interferon induced transmembrane protein 3 |
|
decreases expression | ISO | 11 | 319,673 | 320,914 | RGD:6480464 | CTD | |
| G | IFITM3 | interferon induced transmembrane protein 3 |
|
multiple interactions | ISO | 11 | 319,673 | 320,914 | RGD:6480464 | CTD | |
| G | IFITM3 | interferon induced transmembrane protein 3 |
|
decreases expression | ISO | 11 | 319,673 | 320,914 | RGD:6480464 | CTD | |
| G | IFITM3 | interferon induced transmembrane protein 3 |
|
decreases expression | ISO | 11 | 319,673 | 320,914 | RGD:6480464 | CTD | |
| G | IFNA1 | interferon, alpha 1 |
|
increases expression | ISO | 9 | 21,440,453 | 21,441,315 | RGD:6480464 | CTD | |
| G | IFNAR2 | interferon (alpha, beta and omega) receptor 2 |
|
increases expression | ISO | 21 | 34,602,231 | 34,636,827 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
multiple interactions | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
multiple interactions | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
decreases expression | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNGR1 | interferon gamma receptor 1 |
|
increases expression | ISO | 6 | 137,518,621 | 137,540,567 | RGD:6480464 | CTD | |
| G | IFNGR2 | interferon gamma receptor 2 (interferon gamma transducer 1) |
|
increases expression | ISO | 21 | 34,775,202 | 34,809,828 | RGD:6480464 | CTD | |
| G | IFRD1 | interferon-related developmental regulator 1 |
|
increases expression | ISO | 7 | 112,063,199 | 112,117,258 | RGD:6480464 | CTD | |
| G | IFRD1 | interferon-related developmental regulator 1 |
|
increases expression | ISO | 7 | 112,063,199 | 112,117,258 | RGD:6480464 | CTD | |
| G | IFRD2 | interferon-related developmental regulator 2 |
|
multiple interactions | ISO | 3 | 50,325,163 | 50,330,026 | RGD:6480464 | CTD | |
| G | IFT122 | intraflagellar transport 122 homolog (Chlamydomonas) |
|
multiple interactions | EXP | 3 | 129,158,968 | 129,239,191 | RGD:6480464 | CTD | |
| G | IFT172 | intraflagellar transport 172 homolog (Chlamydomonas) |
|
decreases expression | ISO | 2 | 27,667,240 | 27,712,571 | RGD:6480464 | CTD | |
| G | IFT52 | intraflagellar transport 52 homolog (Chlamydomonas) |
|
multiple interactions | EXP | 20 | 42,219,579 | 42,275,862 | RGD:6480464 | CTD | |
| G | IFT74 | intraflagellar transport 74 homolog (Chlamydomonas) |
|
decreases expression | ISO | 9 | 26,947,037 | 27,062,931 | RGD:6480464 | CTD | |
| G | IGDCC4 | immunoglobulin superfamily, DCC subclass, member 4 |
|
multiple interactions | ISO | 15 | 65,673,825 | 65,715,410 | RGD:6480464 | CTD | |
| G | IGDCC4 | immunoglobulin superfamily, DCC subclass, member 4 |
|
increases expression | ISO | 15 | 65,673,825 | 65,715,410 | RGD:6480464 | CTD | |
| G | IGF1 | insulin-like growth factor 1 (somatomedin C) |
|
multiple interactions | ISO | 12 | 102,789,645 | 102,874,378 | RGD:6480464 | CTD | |
| G | IGF1 | insulin-like growth factor 1 (somatomedin C) |
|
decreases expression | ISO | 12 | 102,789,645 | 102,874,378 | RGD:6480464 | CTD | |
| G | IGF1 | insulin-like growth factor 1 (somatomedin C) |
|
multiple interactions | ISO | 12 | 102,789,645 | 102,874,378 | RGD:6480464 | CTD | |
| G | IGF1 | insulin-like growth factor 1 (somatomedin C) |
|
affects expression | ISO | 12 | 102,789,645 | 102,874,378 | RGD:6480464 | CTD | |
| G | IGF2BP2 | insulin-like growth factor 2 mRNA binding protein 2 |
|
multiple interactions | EXP | 3 | 185,361,527 | 185,542,827 | RGD:6480464 | CTD | |
| G | IGF2BP2 | insulin-like growth factor 2 mRNA binding protein 2 |
|
multiple interactions | ISO | 3 | 185,361,527 | 185,542,827 | RGD:6480464 | CTD | |
| G | IGF2BP3 | insulin-like growth factor 2 mRNA binding protein 3 |
|
multiple interactions | EXP | 7 | 23,349,828 | 23,509,995 | RGD:6480464 | CTD | |
| G | IGF2R | insulin-like growth factor 2 receptor |
|
multiple interactions | ISO | 6 | 160,390,131 | 160,527,583 | RGD:6480464 | CTD | |
| G | IGF2R | insulin-like growth factor 2 receptor |
|
increases expression | ISO | 6 | 160,390,131 | 160,527,583 | RGD:6480464 | CTD | |
| G | IGF2R | insulin-like growth factor 2 receptor |
|
decreases expression | ISO | 6 | 160,390,131 | 160,527,583 | RGD:6480464 | CTD | |
| G | IGF2R | insulin-like growth factor 2 receptor |
|
increases expression | ISO | 6 | 160,390,131 | 160,527,583 | RGD:6480464 | CTD | |
| G | IL17A | interleukin 17A |
|
multiple interactions | ISO | 6 | 52,051,185 | 52,055,436 | RGD:6480464 | CTD | |
| G | IL1R1 | interleukin 1 receptor, type I |
|
increases expression | ISO | 2 | 102,770,402 | 102,796,334 | RGD:6480464 | CTD | |
| G | IL1RAP | interleukin 1 receptor accessory protein |
|
decreases expression | ISO | 3 | 190,231,840 | 190,374,986 | RGD:6480464 | CTD | |
| G | IL1RAP | interleukin 1 receptor accessory protein |
|
multiple interactions | ISO | 3 | 190,231,840 | 190,374,986 | RGD:6480464 | CTD | |
| G | IL1RL1 | interleukin 1 receptor-like 1 |
|
multiple interactions | EXP | 2 | 102,927,962 | 102,968,497 | RGD:6480464 | CTD | |
| G | IL1RN | interleukin 1 receptor antagonist |
|
multiple interactions | EXP | 2 | 113,875,470 | 113,891,593 | RGD:6480464 | CTD | |
| G | IL1RN | interleukin 1 receptor antagonist |
|
multiple interactions | ISO | 2 | 113,875,470 | 113,891,593 | RGD:6480464 | CTD | |
| G | IL1RN | interleukin 1 receptor antagonist |
|
multiple interactions | ISO | 2 | 113,875,470 | 113,891,593 | RGD:6480464 | CTD | |
| G | IL1RN | interleukin 1 receptor antagonist |
|
increases expression | ISO | 2 | 113,875,470 | 113,891,593 | RGD:6480464 | CTD | |
| G | IL1RN | interleukin 1 receptor antagonist |
|
increases expression | ISO | 2 | 113,875,470 | 113,891,593 | RGD:6480464 | CTD | |
| G | IL1RN | interleukin 1 receptor antagonist |
|
multiple interactions | ISO | 2 | 113,875,470 | 113,891,593 | RGD:6480464 | CTD | |
| G | IL1RN | interleukin 1 receptor antagonist |
|
increases expression | ISO | 2 | 113,875,470 | 113,891,593 | RGD:6480464 | CTD | |
| G | IL21 | interleukin 21 |
|
multiple interactions | EXP | 4 | 123,533,783 | 123,542,212 | RGD:6480464 | CTD | |
| G | IL22RA2 | interleukin 22 receptor, alpha 2 |
|
multiple interactions | EXP | 6 | 137,464,957 | 137,494,785 | RGD:6480464 | CTD | |
| G | IL2RB | interleukin 2 receptor, beta |
|
decreases expression | ISO | 22 | 37,521,878 | 37,545,962 | RGD:6480464 | CTD | |
| G | IL2RB | interleukin 2 receptor, beta |
|
decreases expression | ISO | 22 | 37,521,878 | 37,545,962 | RGD:6480464 | CTD | |
| G | IL2RB | interleukin 2 receptor, beta |
|
multiple interactions | ISO | 22 | 37,521,878 | 37,545,962 | RGD:6480464 | CTD | |
| G | IL2RG | interleukin 2 receptor, gamma |
|
multiple interactions | ISO | X | 70,327,254 | 70,331,481 | RGD:6480464 | CTD | |
| G | IL31 | interleukin 31 |
|
decreases expression | ISO | 12 | 122,656,577 | 122,658,746 | RGD:6480464 | CTD | |
| G | IL33 | interleukin 33 |
|
decreases expression | ISO | 9 | 6,215,786 | 6,257,983 | RGD:6480464 | CTD | |
| G | IL33 | interleukin 33 |
|
decreases expression | ISO | 9 | 6,215,786 | 6,257,983 | RGD:6480464 | CTD | |
| G | IL33 | interleukin 33 |
|
multiple interactions | ISO | 9 | 6,215,786 | 6,257,983 | RGD:6480464 | CTD | |
| G | IL34 | interleukin 34 |
|
multiple interactions | ISO | 16 | 70,613,798 | 70,694,585 | RGD:6480464 | CTD | |
| G | IL36A | interleukin 36, alpha |
|
multiple interactions | EXP | 2 | 113,763,449 | 113,765,621 | RGD:6480464 | CTD | |
| G | IL4 | interleukin 4 |
|
decreases expression | ISO | 5 | 132,009,678 | 132,018,370 | RGD:6480464 | CTD | |
| G | IL4 | interleukin 4 |
|
multiple interactions | ISO | 5 | 132,009,678 | 132,018,370 | RGD:6480464 | CTD | |
| G | IL4 | interleukin 4 |
|
increases expression | ISO | 5 | 132,009,678 | 132,018,370 | RGD:6480464 | CTD | |
| G | IL4R | interleukin 4 receptor |
|
decreases expression | ISO | 16 | 27,325,230 | 27,376,099 | RGD:6480464 | CTD | |
| G | IL5 | interleukin 5 (colony-stimulating factor, eosinophil) |
|
decreases expression | ISO | 5 | 131,877,136 | 131,879,214 | RGD:6480464 | CTD | |
| G | IL6 | interleukin 6 (interferon, beta 2) |
|
multiple interactions | ISO | 7 | 22,766,766 | 22,771,621 | RGD:6480464 | CTD | |
| G | IL6 | interleukin 6 (interferon, beta 2) |
|
decreases expression | ISO | 7 | 22,766,766 | 22,771,621 | RGD:6480464 | CTD | |
| G | IL6 | interleukin 6 (interferon, beta 2) |
|
increases expression | ISO | 7 | 22,766,766 | 22,771,621 | RGD:6480464 | CTD | |
| G | IL6 | interleukin 6 (interferon, beta 2) |
|
multiple interactions | ISO | 7 | 22,766,766 | 22,771,621 | RGD:6480464 | CTD | |
| G | IL6R | interleukin 6 receptor |
|
decreases expression | ISO | 1 | 154,377,669 | 154,441,926 | RGD:6480464 | CTD | |
| G | IL6R | interleukin 6 receptor |
|
multiple interactions | ISO | 1 | 154,377,669 | 154,441,926 | RGD:6480464 | CTD | |
| G | IL6R | interleukin 6 receptor |
|
decreases expression | ISO | 1 | 154,377,669 | 154,441,926 | RGD:6480464 | CTD | |
| G | IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) |
|
decreases expression | ISO | 5 | 55,230,923 | 55,290,821 | RGD:6480464 | CTD | |
| G | IL7 | interleukin 7 |
|
multiple interactions | EXP | 8 | 79,645,007 | 79,717,758 | RGD:6480464 | CTD | |
| G | IL9 | interleukin 9 |
|
multiple interactions | ISO | 5 | 135,227,935 | 135,231,516 | RGD:6480464 | CTD | |
| G | ILK | integrin-linked kinase |
|
multiple interactions | EXP | 11 | 6,624,964 | 6,632,101 | RGD:6480464 | CTD | |
| G | ILVBL | ilvB (bacterial acetolactate synthase)-like |
|
multiple interactions | EXP | 19 | 15,225,785 | 15,236,577 | RGD:6480464 | CTD | |
| G | ILVBL | ilvB (bacterial acetolactate synthase)-like |
|
increases expression | ISO | 19 | 15,225,785 | 15,236,577 | RGD:6480464 | CTD | |
| G | IMMP1L | IMP1 inner mitochondrial membrane peptidase-like (S. cerevisiae) |
|
decreases expression | ISO | 11 | 31,453,949 | 31,531,169 | RGD:6480464 | CTD | |
| G | IMMT | inner membrane protein, mitochondrial |
|
increases expression | ISO | 2 | 86,371,055 | 86,422,893 | RGD:6480464 | CTD | |
| G | IMPA1 | inositol(myo)-1(or 4)-monophosphatase 1 |
|
decreases expression | ISO | 8 | 82,569,151 | 82,598,589 | RGD:6480464 | CTD | |
| G | IMPA1 | inositol(myo)-1(or 4)-monophosphatase 1 |
|
increases expression | ISO | 8 | 82,569,151 | 82,598,589 | RGD:6480464 | CTD | |
| G | IMPA2 | inositol(myo)-1(or 4)-monophosphatase 2 |
|
increases expression | ISO | 18 | 11,981,427 | 12,030,885 | RGD:6480464 | CTD | |
| G | IMPA2 | inositol(myo)-1(or 4)-monophosphatase 2 |
|
increases expression | ISO | 18 | 11,981,427 | 12,030,885 | RGD:6480464 | CTD | |
| G | IMPACT | impact RWD domain protein |
|
increases expression | ISO | 18 | 22,006,609 | 22,033,495 | RGD:6480464 | CTD | |
| G | IPO11 | importin 11 |
|
multiple interactions | ISO | 5 | 61,708,573 | 61,924,416 | RGD:6480464 | CTD | |
| G | IRF8 | interferon regulatory factor 8 |
|
multiple interactions | EXP | 16 | 85,932,774 | 85,956,212 | RGD:6480464 | CTD | |
| G | IRGM | immunity-related GTPase family, M |
|
decreases expression | ISO | 5 | 150,226,085 | 150,228,231 | RGD:6480464 | CTD | |
| G | IRGM | immunity-related GTPase family, M |
|
decreases expression | ISO | 5 | 150,226,085 | 150,228,231 | RGD:6480464 | CTD | |
| G | IRS1 | insulin receptor substrate 1 |
|
increases expression | ISO | 2 | 227,596,033 | 227,663,506 | RGD:6480464 | CTD | |
| G | IRS1 | insulin receptor substrate 1 |
|
decreases expression | ISO | 2 | 227,596,033 | 227,663,506 | RGD:6480464 | CTD | |
| G | IRS2 | insulin receptor substrate 2 |
|
increases expression | ISO | 13 | 110,406,184 | 110,438,914 | RGD:6480464 | CTD | |
| G | IRS4 | insulin receptor substrate 4 |
|
multiple interactions | ISO | X | 107,975,727 | 107,979,607 | RGD:6480464 | CTD | |
| G | IRS4 | insulin receptor substrate 4 |
|
decreases expression | ISO | X | 107,975,727 | 107,979,607 | RGD:6480464 | CTD | |
| G | IRS4 | insulin receptor substrate 4 |
|
affects expression | ISO | X | 107,975,727 | 107,979,607 | RGD:6480464 | CTD | |
| G | IRX3 | iroquois homeobox 3 |
|
multiple interactions | ISO | 16 | 54,317,212 | 54,320,378 | RGD:6480464 | CTD | |
| G | IRX5 | iroquois homeobox 5 |
|
increases expression | ISO | 16 | 54,965,111 | 54,968,397 | RGD:6480464 | CTD | |
| G | ISLR | immunoglobulin superfamily containing leucine-rich repeat |
|
decreases expression | ISO | 15 | 74,466,087 | 74,469,212 | RGD:6480464 | CTD | |
| G | ISOC1 | isochorismatase domain containing 1 |
|
increases expression | ISO | 5 | 128,430,442 | 128,449,721 | RGD:6480464 | CTD | |
| G | ISYNA1 | inositol-3-phosphate synthase 1 |
|
affects expression | ISO | 19 | 18,545,198 | 18,549,111 | RGD:6480464 | CTD | |
| G | ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) |
|
multiple interactions | ISO | 17 | 48,133,340 | 48,167,849 | RGD:6480464 | CTD | |
| G | ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) |
|
affects expression | ISO | 17 | 48,133,340 | 48,167,849 | RGD:6480464 | CTD | |
| G | ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) |
|
decreases expression | ISO | 17 | 48,133,340 | 48,167,849 | RGD:6480464 | CTD | |
| G | ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) |
|
multiple interactions | ISO | 17 | 48,133,340 | 48,167,849 | RGD:6480464 | CTD | |
| G | ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) |
|
affects expression | ISO | 17 | 48,133,340 | 48,167,849 | RGD:6480464 | CTD | |
| G | ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) |
|
decreases expression | ISO | 17 | 48,133,340 | 48,167,849 | RGD:6480464 | CTD | |
| G | ITGA6 | integrin, alpha 6 |
|
multiple interactions | EXP | 2 | 173,292,314 | 173,371,181 | RGD:6480464 | CTD | |
| G | ITGA6 | integrin, alpha 6 |
|
increases expression | ISO | 2 | 173,292,314 | 173,371,181 | RGD:6480464 | CTD | |
| G | ITGA7 | integrin, alpha 7 |
|
decreases expression | ISO | 12 | 56,078,352 | 56,106,089 | RGD:6480464 | CTD | |
| G | ITGA7 | integrin, alpha 7 |
|
multiple interactions | ISO | 12 | 56,078,352 | 56,106,089 | RGD:6480464 | CTD | |
| G | ITGAE | integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide) |
|
decreases expression | ISO | 17 | 3,617,919 | 3,704,537 | RGD:6480464 | CTD | |
| G | ITGAE | integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide) |
|
increases expression | ISO | 17 | 3,617,919 | 3,704,537 | RGD:6480464 | CTD | |
| G | ITGAV | integrin, alpha V |
|
multiple interactions | ISO | 2 | 187,454,790 | 187,545,628 | RGD:6480464 | CTD | |
| G | ITGAV | integrin, alpha V |
|
decreases expression | ISO | 2 | 187,454,790 | 187,545,628 | RGD:6480464 | CTD | |
| G | ITGAX | integrin, alpha X (complement component 3 receptor 4 subunit) |
|
decreases expression | ISO | 16 | 31,366,509 | 31,394,318 | RGD:6480464 | CTD | |
| G | ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
|
increases expression | ISO | 10 | 33,189,246 | 33,247,293 | RGD:6480464 | CTD | |
| G | ITGB1BP1 | integrin beta 1 binding protein 1 |
|
affects expression | ISO | 2 | 9,545,813 | 9,563,643 | RGD:6480464 | CTD | |
| G | ITGB1BP1 | integrin beta 1 binding protein 1 |
|
multiple interactions | EXP | 2 | 9,545,813 | 9,563,643 | RGD:6480464 | CTD | |
| G | ITGB2 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
|
multiple interactions | EXP | 21 | 46,305,868 | 46,348,753 | RGD:6480464 | CTD | |
| G | ITGB2 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
|
decreases expression | ISO | 21 | 46,305,868 | 46,348,753 | RGD:6480464 | CTD | |
| G | ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
|
multiple interactions | ISO | 17 | 45,331,208 | 45,390,077 | RGD:6480464 | CTD | |
| G | ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
|
decreases expression | ISO | 17 | 45,331,208 | 45,390,077 | RGD:6480464 | CTD | |
| G | ITGB5 | integrin, beta 5 |
|
decreases expression | ISO | 3 | 124,481,795 | 124,606,144 | RGD:6480464 | CTD | |
| G | ITGB6 | integrin, beta 6 |
|
multiple interactions | EXP | 2 | 160,958,233 | 161,056,590 | RGD:6480464 | CTD | |
| G | ITGB7 | integrin, beta 7 |
|
multiple interactions | ISO | 12 | 53,585,107 | 53,601,000 | RGD:6480464 | CTD | |
| G | ITIH1 | inter-alpha-trypsin inhibitor heavy chain 1 |
|
decreases expression | ISO | 3 | 52,811,602 | 52,826,084 | RGD:6480464 | CTD | |
| G | ITIH1 | inter-alpha-trypsin inhibitor heavy chain 1 |
|
multiple interactions | ISO | 3 | 52,811,602 | 52,826,084 | RGD:6480464 | CTD | |
| G | ITIH2 | inter-alpha-trypsin inhibitor heavy chain 2 |
|
multiple interactions | ISO | 10 | 7,745,236 | 7,791,483 | RGD:6480464 | CTD | |
| G | ITIH3 | inter-alpha-trypsin inhibitor heavy chain 3 |
|
increases expression | ISO | 3 | 52,828,784 | 52,843,025 | RGD:6480464 | CTD | |
| G | ITIH4 | inter-alpha-trypsin inhibitor heavy chain family, member 4 |
|
multiple interactions | EXP | 3 | 52,847,006 | 52,864,717 | RGD:6480464 | CTD | |
| G | ITIH4 | inter-alpha-trypsin inhibitor heavy chain family, member 4 |
|
multiple interactions | ISO | 3 | 52,847,006 | 52,864,717 | RGD:6480464 | CTD | |
| G | ITIH4 | inter-alpha-trypsin inhibitor heavy chain family, member 4 |
|
decreases expression | ISO | 3 | 52,847,006 | 52,864,717 | RGD:6480464 | CTD | |
| G | ITIH4 | inter-alpha-trypsin inhibitor heavy chain family, member 4 |
|
affects expression | ISO | 3 | 52,847,006 | 52,864,717 | RGD:6480464 | CTD | |
| G | ITIH4 | inter-alpha-trypsin inhibitor heavy chain family, member 4 |
|
multiple interactions | ISO | 3 | 52,847,006 | 52,864,717 | RGD:6480464 | CTD | |
| G | ITIH4 | inter-alpha-trypsin inhibitor heavy chain family, member 4 |
|
decreases expression | ISO | 3 | 52,847,006 | 52,864,717 | RGD:6480464 | CTD | |
| G | ITLN1 | intelectin 1 (galactofuranose binding) |
|
decreases expression | ISO | 1 | 160,846,330 | 160,854,960 | RGD:6480464 | CTD | |
| G | ITPA | inosine triphosphatase (nucleoside triphosphate pyrophosphatase) |
|
multiple interactions | EXP | 20 | 3,189,514 | 3,204,516 | RGD:6480464 | CTD | |
| G | ITPK1 | inositol-tetrakisphosphate 1-kinase |
|
increases expression | ISO | 14 | 93,403,259 | 93,582,263 | RGD:6480464 | CTD | |
| G | ITPKA | inositol-trisphosphate 3-kinase A |
|
decreases expression | ISO | 15 | 41,786,056 | 41,795,757 | RGD:6480464 | CTD | |
| G | KAT6B | K(lysine) acetyltransferase 6B |
|
increases expression | ISO | 10 | 76,586,171 | 76,792,380 | RGD:6480464 | CTD | |
| G | KAT8 | K(lysine) acetyltransferase 8 |
|
increases expression | ISO | 16 | 31,128,985 | 31,142,714 | RGD:6480464 | CTD | |
| G | KDELR2 | KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 |
|
affects expression | ISO | 7 | 6,500,712 | 6,523,849 | RGD:6480464 | CTD | |
| G | KDM5C | lysine (K)-specific demethylase 5C |
|
increases expression | ISO | X | 53,220,503 | 53,254,604 | RGD:6480464 | CTD | |
| G | KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) |
|
decreases expression | ISO | 4 | 55,944,426 | 55,991,762 | RGD:6480464 | CTD | |
| G | KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) |
|
affects expression | ISO | 4 | 55,944,426 | 55,991,762 | RGD:6480464 | CTD | |
| G | KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) |
|
multiple interactions | ISO | 4 | 55,944,426 | 55,991,762 | RGD:6480464 | CTD | |
| G | KDSR | 3-ketodihydrosphingosine reductase |
|
increases expression | ISO | 18 | 60,994,971 | 61,034,506 | RGD:6480464 | CTD | |
| G | KEAP1 | kelch-like ECH-associated protein 1 |
|
multiple interactions | EXP | 19 | 10,596,796 | 10,614,054 | RGD:6480464 | CTD | |
| G | KHDRBS1 | KH domain containing, RNA binding, signal transduction associated 1 |
|
increases expression | ISO | 1 | 32,479,491 | 32,509,472 | RGD:6480464 | CTD | |
| G | KHDRBS3 | KH domain containing, RNA binding, signal transduction associated 3 |
|
multiple interactions | EXP | 8 | 136,469,716 | 136,659,849 | RGD:6480464 | CTD | |
| G | KHDRBS3 | KH domain containing, RNA binding, signal transduction associated 3 |
|
increases expression | ISO | 8 | 136,469,716 | 136,659,849 | RGD:6480464 | CTD | |
| G | KHK | ketohexokinase (fructokinase) |
|
decreases expression | ISO | 2 | 27,309,611 | 27,323,619 | RGD:6480464 | CTD | |
| G | KHK | ketohexokinase (fructokinase) |
|
multiple interactions | ISO | 2 | 27,309,611 | 27,323,619 | RGD:6480464 | CTD | |
| G | KHK | ketohexokinase (fructokinase) |
|
decreases expression | ISO | 2 | 27,309,611 | 27,323,619 | RGD:6480464 | CTD | |
| G | KIAA1715 | KIAA1715 |
|
increases expression | ISO | 2 | 176,790,410 | 176,867,018 | RGD:6480464 | CTD | |
| G | KIF14 | kinesin family member 14 |
|
multiple interactions | ISO | 1 | 200,520,625 | 200,589,862 | RGD:6480464 | CTD | |
| G | KIF14 | kinesin family member 14 |
|
increases expression | ISO | 1 | 200,520,625 | 200,589,862 | RGD:6480464 | CTD | |
| G | KIF16B | kinesin family member 16B |
|
increases expression | ISO | 20 | 16,252,749 | 16,554,079 | RGD:6480464 | CTD | |
| G | KIF1B | kinesin family member 1B |
|
increases expression | ISO | 1 | 10,270,764 | 10,441,661 | RGD:6480464 | CTD | |
| G | KIF20A | kinesin family member 20A |
|
increases expression | ISO | 5 | 137,514,417 | 137,523,404 | RGD:6480464 | CTD | |
| G | KIF20A | kinesin family member 20A |
|
multiple interactions | ISO | 5 | 137,514,417 | 137,523,404 | RGD:6480464 | CTD | |
| G | KIF20B | kinesin family member 20B |
|
increases expression | ISO | 10 | 91,461,367 | 91,534,700 | RGD:6480464 | CTD | |
| G | KIF20B | kinesin family member 20B |
|
multiple interactions | ISO | 10 | 91,461,367 | 91,534,700 | RGD:6480464 | CTD | |
| G | KIF2C | kinesin family member 2C |
|
increases expression | ISO | 1 | 45,205,490 | 45,233,439 | RGD:6480464 | CTD | |
| G | KIF3C | kinesin family member 3C |
|
multiple interactions | ISO | 2 | 26,149,455 | 26,205,443 | RGD:6480464 | CTD | |
| G | KIF3C | kinesin family member 3C |
|
increases expression | ISO | 2 | 26,149,455 | 26,205,443 | RGD:6480464 | CTD | |
| G | KIF3C | kinesin family member 3C |
|
decreases expression | ISO | 2 | 26,149,455 | 26,205,443 | RGD:6480464 | CTD | |
| G | KIF4A | kinesin family member 4A |
|
increases expression | ISO | X | 69,509,879 | 69,640,774 | RGD:6480464 | CTD | |
| G | KIF4A | kinesin family member 4A |
|
multiple interactions | EXP | X | 69,509,879 | 69,640,774 | RGD:6480464 | CTD | |
| G | KIF5C | kinesin family member 5C |
|
multiple interactions | ISO | 2 2 |
149,793,796 149,632,792 |
149,883,273 149,686,923 |
RGD:6480464 | CTD | |
| G | KIF5C | kinesin family member 5C |
|
increases expression | ISO | 2 2 |
149,793,796 149,632,792 |
149,883,273 149,686,923 |
RGD:6480464 | CTD | |
| G | KIFC1 | kinesin family member C1 |
|
increases expression | ISO | 6 | 33,359,313 | 33,377,701 | RGD:6480464 | CTD | |
| G | KIFC1 | kinesin family member C1 |
|
increases expression | ISO | 6 | 33,359,313 | 33,377,701 | RGD:6480464 | CTD | |
| G | KIRREL | kin of IRRE like (Drosophila) |
|
multiple interactions | ISO | 1 | 157,963,063 | 158,065,846 | RGD:6480464 | CTD | |
| G | KIRREL | kin of IRRE like (Drosophila) |
|
increases expression | ISO | 1 | 157,963,063 | 158,065,846 | RGD:6480464 | CTD | |
| G | KITLG | KIT ligand |
|
decreases expression | ISO | 12 | 88,886,570 | 88,974,250 | RGD:6480464 | CTD | |
| G | KLB | klotho beta |
|
increases expression | ISO | 4 | 39,408,473 | 39,453,153 | RGD:6480464 | CTD | |
| G | KLC3 | kinesin light chain 3 |
|
multiple interactions | ISO | 19 | 45,843,998 | 45,854,778 | RGD:6480464 | CTD | |
| G | KLF1 | Kruppel-like factor 1 (erythroid) |
|
multiple interactions | ISO | 19 | 12,995,236 | 12,998,017 | RGD:6480464 | CTD | |
| G | KLF10 | Kruppel-like factor 10 |
|
multiple interactions | ISO | 8 | 103,661,005 | 103,667,983 | RGD:6480464 | CTD | |
| G | KLF10 | Kruppel-like factor 10 |
|
multiple interactions | EXP | 8 | 103,661,005 | 103,667,983 | RGD:6480464 | CTD | |
| G | KLF10 | Kruppel-like factor 10 |
|
decreases expression | ISO | 8 | 103,661,005 | 103,667,983 | RGD:6480464 | CTD | |
| G | KLF10 | Kruppel-like factor 10 |
|
increases expression | ISO | 8 | 103,661,005 | 103,667,983 | RGD:6480464 | CTD | |
| G | KLF10 | Kruppel-like factor 10 |
|
increases expression | ISO | 8 | 103,661,005 | 103,667,983 | RGD:6480464 | CTD | |
| G | KLF11 | Kruppel-like factor 11 |
|
multiple interactions | ISO | 2 | 10,183,682 | 10,194,963 | RGD:6480464 | CTD | |
| G | KLF11 | Kruppel-like factor 11 |
|
multiple interactions | EXP | 2 | 10,183,682 | 10,194,963 | RGD:6480464 | CTD | |
| G | KLF11 | Kruppel-like factor 11 |
|
increases expression | ISO | 2 | 10,183,682 | 10,194,963 | RGD:6480464 | CTD | |
| G | KLF12 | Kruppel-like factor 12 |
|
multiple interactions | ISO | 13 | 74,260,149 | 74,708,066 | RGD:6480464 | CTD | |
| G | KLF12 | Kruppel-like factor 12 |
|
multiple interactions | ISO | 13 | 74,260,149 | 74,708,066 | RGD:6480464 | CTD | |
| G | KLF12 | Kruppel-like factor 12 |
|
decreases expression | ISO | 13 | 74,260,149 | 74,708,066 | RGD:6480464 | CTD | |
| G | KLF13 | Kruppel-like factor 13 |
|
multiple interactions | ISO | 15 | 31,619,083 | 31,670,102 | RGD:6480464 | CTD | |
| G | KLF13 | Kruppel-like factor 13 |
|
decreases expression | ISO | 15 | 31,619,083 | 31,670,102 | RGD:6480464 | CTD | |
| G | KLF15 | Kruppel-like factor 15 |
|
increases expression | ISO | 3 | 126,061,478 | 126,076,236 | RGD:6480464 | CTD | |
| G | KMT2A | lysine (K)-specific methyltransferase 2A |
|
decreases expression | ISO | 11 | 118,307,205 | 118,397,539 | RGD:6480464 | CTD | |
| G | KMT2E | lysine (K)-specific methyltransferase 2E |
|
decreases expression | ISO | 7 | 104,654,637 | 104,754,532 | RGD:6480464 | CTD | |
| G | KPNA2 | karyopherin alpha 2 (RAG cohort 1, importin alpha 1) |
|
increases expression | ISO | 17 | 66,031,848 | 66,042,970 | RGD:6480464 | CTD | |
| G | LAMA5 | laminin, alpha 5 |
|
multiple interactions | EXP | 20 | 60,884,121 | 60,942,368 | RGD:6480464 | CTD | |
| G | LAMB3 | laminin, beta 3 |
|
multiple interactions | ISO | 1 | 209,788,215 | 209,825,820 | RGD:6480464 | CTD | |
| G | LAMB3 | laminin, beta 3 |
|
multiple interactions | ISO | 1 | 209,788,215 | 209,825,820 | RGD:6480464 | CTD | |
| G | LAMB3 | laminin, beta 3 |
|
increases expression | ISO | 1 | 209,788,215 | 209,825,820 | RGD:6480464 | CTD | |
| G | LAMC1 | laminin, gamma 1 (formerly LAMB2) |
|
increases expression | ISO | 1 | 182,992,595 | 183,114,727 | RGD:6480464 | CTD | |
| G | LANCL1 | LanC lantibiotic synthetase component C-like 1 (bacterial) |
|
decreases expression | ISO | 2 | 211,295,973 | 211,341,499 | RGD:6480464 | CTD | |
| G | LANCL2 | LanC lantibiotic synthetase component C-like 2 (bacterial) |
|
multiple interactions | ISO | 7 | 55,433,141 | 55,501,435 | RGD:6480464 | CTD | |
| G | LANCL2 | LanC lantibiotic synthetase component C-like 2 (bacterial) |
|
increases expression | ISO | 7 | 55,433,141 | 55,501,435 | RGD:6480464 | CTD | |
| G | LAP3 | leucine aminopeptidase 3 |
|
decreases expression | ISO | 4 | 17,578,927 | 17,609,590 | RGD:6480464 | CTD | |
| G | LAPTM4A | lysosomal protein transmembrane 4 alpha |
|
increases expression | ISO | 2 | 20,232,411 | 20,251,789 | RGD:6480464 | CTD | |
| G | LAPTM4B | lysosomal protein transmembrane 4 beta |
|
decreases expression | ISO | 8 | 98,787,809 | 98,864,830 | RGD:6480464 | CTD | |
| G | LAPTM5 | lysosomal protein transmembrane 5 |
|
decreases expression | ISO | 1 | 31,205,315 | 31,230,683 | RGD:6480464 | CTD | |
| G | LARGE | like-glycosyltransferase |
|
increases expression | ISO | 22 | 33,669,062 | 34,316,416 | RGD:6480464 | CTD | |
| G | LARGE | like-glycosyltransferase |
|
increases expression | ISO | 22 | 33,669,062 | 34,316,416 | RGD:6480464 | CTD | |
| G | LARP1 | La ribonucleoprotein domain family, member 1 |
|
multiple interactions | ISO | 5 | 154,092,462 | 154,197,165 | RGD:6480464 | CTD | |
| G | LARS | leucyl-tRNA synthetase |
|
increases expression | ISO | 5 | 145,492,589 | 145,562,294 | RGD:6480464 | CTD | |
| G | LARS | leucyl-tRNA synthetase |
|
decreases expression | ISO | 5 | 145,492,589 | 145,562,294 | RGD:6480464 | CTD | |
| G | LARS2 | leucyl-tRNA synthetase 2, mitochondrial |
|
decreases expression | ISO | 3 | 45,430,075 | 45,590,328 | RGD:6480464 | CTD | |
| G | LAS1L | LAS1-like (S. cerevisiae) |
|
multiple interactions | ISO | X | 64,732,462 | 64,754,686 | RGD:6480464 | CTD | |
| G | LAS1L | LAS1-like (S. cerevisiae) |
|
multiple interactions | EXP | X | 64,732,462 | 64,754,686 | RGD:6480464 | CTD | |
| G | LAS1L | LAS1-like (S. cerevisiae) |
|
increases expression | ISO | X | 64,732,462 | 64,754,686 | RGD:6480464 | CTD | |
| G | LASP1 | LIM and SH3 protein 1 |
|
decreases expression | ISO | 17 | 37,026,112 | 37,078,023 | RGD:6480464 | CTD | |
| G | LAT | linker for activation of T cells |
|
decreases expression | ISO | 16 | 28,996,147 | 29,002,104 | RGD:6480464 | CTD | |
| G | LAT2 | linker for activation of T cells family, member 2 |
|
multiple interactions | EXP | 7 | 73,624,087 | 73,644,164 | RGD:6480464 | CTD | |
| G | LBH | limb bud and heart development |
|
increases expression | ISO | 2 | 30,454,397 | 30,482,899 | RGD:6480464 | CTD | |
| G | LBP | lipopolysaccharide binding protein |
|
increases expression | ISO | 20 | 36,974,814 | 37,005,653 | RGD:6480464 | CTD | |
| G | LBP | lipopolysaccharide binding protein |
|
multiple interactions | ISO | 20 | 36,974,814 | 37,005,653 | RGD:6480464 | CTD | |
| G | LCAT | lecithin-cholesterol acyltransferase |
|
affects expression | ISO | 16 | 67,973,787 | 67,978,015 | RGD:6480464 | CTD | |
| G | LCAT | lecithin-cholesterol acyltransferase |
|
increases expression | ISO | 16 | 67,973,787 | 67,978,015 | RGD:6480464 | CTD | |
| G | LCAT | lecithin-cholesterol acyltransferase |
|
decreases expression | ISO | 16 | 67,973,787 | 67,978,015 | RGD:6480464 | CTD | |
| G | LCK | lymphocyte-specific protein tyrosine kinase |
|
decreases expression | ISO | 1 | 32,716,840 | 32,751,766 | RGD:6480464 | CTD | |
| G | LCMT1 | leucine carboxyl methyltransferase 1 |
|
affects expression | ISO | 16 | 25,123,047 | 25,189,551 | RGD:6480464 | CTD | |
| G | LCN12 | lipocalin 12 |
|
multiple interactions | EXP | 9 | 139,846,768 | 139,849,949 | RGD:6480464 | CTD | |
| G | LCN2 | lipocalin 2 |
|
decreases expression | ISO | 9 | 130,911,732 | 130,915,734 | RGD:6480464 | CTD | |
| G | LCN2 | lipocalin 2 |
|
increases expression | ISO | 9 | 130,911,732 | 130,915,734 | RGD:6480464 | CTD | |
| G | LCN2 | lipocalin 2 |
|
multiple interactions | ISO | 9 | 130,911,732 | 130,915,734 | RGD:6480464 | CTD | |
| G | LCP1 | lymphocyte cytosolic protein 1 (L-plastin) |
|
decreases expression | ISO | 13 | 46,700,058 | 46,756,459 | RGD:6480464 | CTD | |
| G | LCP1 | lymphocyte cytosolic protein 1 (L-plastin) |
|
multiple interactions | ISO | 13 | 46,700,058 | 46,756,459 | RGD:6480464 | CTD | |
| G | LCT | lactase |
|
decreases expression | ISO | 2 | 136,545,415 | 136,594,750 | RGD:6480464 | CTD | |
| G | LDB3 | LIM domain binding 3 |
|
increases expression | ISO | 10 | 88,428,206 | 88,495,825 | RGD:6480464 | CTD | |
| G | LDB3 | LIM domain binding 3 |
|
increases expression | ISO | 10 | 88,428,206 | 88,495,825 | RGD:6480464 | CTD | |
| G | LDHA | lactate dehydrogenase A |
|
increases expression | ISO | 11 | 18,415,936 | 18,429,765 | RGD:6480464 | CTD | |
| G | LDHB | lactate dehydrogenase B |
|
multiple interactions | ISO | 12 | 21,788,275 | 21,810,789 | RGD:6480464 | CTD | |
| G | LDHD | lactate dehydrogenase D |
|
decreases expression | ISO | 16 | 75,145,758 | 75,150,670 | RGD:6480464 | CTD | |
| G | LDLR | low density lipoprotein receptor |
|
decreases expression | ISO | 19 | 11,200,038 | 11,244,506 | RGD:6480464 | CTD | |
| G | LDLR | low density lipoprotein receptor |
|
affects expression | ISO | 19 | 11,200,038 | 11,244,506 | RGD:6480464 | CTD | |
| G | LDLR | low density lipoprotein receptor |
|
increases expression | ISO | 19 | 11,200,038 | 11,244,506 | RGD:6480464 | CTD | |
| G | LEAP2 | liver expressed antimicrobial peptide 2 |
|
decreases expression | ISO | 5 | 132,209,358 | 132,210,582 | RGD:6480464 | CTD | |
| G | LECT1 | leukocyte cell derived chemotaxin 1 |
|
decreases expression | ISO | 13 | 53,277,399 | 53,313,947 | RGD:6480464 | CTD | |
| G | LECT1 | leukocyte cell derived chemotaxin 1 |
|
increases expression | ISO | 13 | 53,277,399 | 53,313,947 | RGD:6480464 | CTD | |
| G | LECT2 | leukocyte cell-derived chemotaxin 2 |
|
multiple interactions | EXP | 5 | 135,282,600 | 135,290,723 | RGD:6480464 | CTD | |
| G | LECT2 | leukocyte cell-derived chemotaxin 2 |
|
decreases expression | ISO | 5 | 135,282,600 | 135,290,723 | RGD:6480464 | CTD | |
| G | LECT2 | leukocyte cell-derived chemotaxin 2 |
|
multiple interactions | ISO | 5 | 135,282,600 | 135,290,723 | RGD:6480464 | CTD | |
| G | LEF1 | lymphoid enhancer-binding factor 1 |
|
increases expression | ISO | 4 | 108,968,701 | 109,090,112 | RGD:6480464 | CTD | |
| G | LENG1 | leukocyte receptor cluster (LRC) member 1 |
|
multiple interactions | ISO | 19 | 54,659,377 | 54,663,446 | RGD:6480464 | CTD | |
| G | LENG9 | leukocyte receptor cluster (LRC) member 9 |
|
decreases expression | ISO | 19 | 54,972,976 | 54,974,894 | RGD:6480464 | CTD | |
| G | LEO1 | Leo1, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae) |
|
multiple interactions | ISO | 15 | 52,230,222 | 52,263,958 | RGD:6480464 | CTD | |
| G | LNX1 | ligand of numb-protein X 1, E3 ubiquitin protein ligase |
|
affects expression | ISO | 4 | 54,326,437 | 54,457,753 | RGD:6480464 | CTD | |
| G | LONP2 | lon peptidase 2, peroxisomal |
|
increases expression | ISO | 16 | 48,278,211 | 48,387,407 | RGD:6480464 | CTD | |
| G | LONP2 | lon peptidase 2, peroxisomal |
|
multiple interactions | ISO | 16 | 48,278,211 | 48,387,407 | RGD:6480464 | CTD | |
| G | LONRF2 | LON peptidase N-terminal domain and ring finger 2 |
|
increases expression | ISO | 2 | 100,889,753 | 100,939,195 | RGD:6480464 | CTD | |
| G | LONRF3 | LON peptidase N-terminal domain and ring finger 3 |
|
multiple interactions | ISO | X | 118,108,713 | 118,151,950 | RGD:6480464 | CTD | |
| G | LOR | loricrin |
|
increases expression | ISO | 1 | 153,232,179 | 153,234,600 | RGD:6480464 | CTD | |
| G | LOX | lysyl oxidase |
|
affects expression | ISO | 5 | 121,398,890 | 121,414,055 | RGD:6480464 | CTD | |
| G | LPAR4 | lysophosphatidic acid receptor 4 |
|
multiple interactions | EXP | X | 78,003,206 | 78,012,588 | RGD:6480464 | CTD | |
| G | LPCAT1 | lysophosphatidylcholine acyltransferase 1 |
|
multiple interactions | EXP | 5 | 1,461,542 | 1,524,076 | RGD:6480464 | CTD | |
| G | LPCAT3 | lysophosphatidylcholine acyltransferase 3 |
|
increases expression | ISO | 12 | 7,085,347 | 7,125,842 | RGD:6480464 | CTD | |
| G | LPGAT1 | lysophosphatidylglycerol acyltransferase 1 |
|
increases expression | ISO | 1 | 211,916,799 | 212,004,114 | RGD:6480464 | CTD | |
| G | LPHN2 | latrophilin 2 |
|
multiple interactions | ISO | 1 | 82,266,082 | 82,458,107 | RGD:6480464 | CTD | |
| G | LPHN2 | latrophilin 2 |
|
decreases expression | ISO | 1 | 82,266,082 | 82,458,107 | RGD:6480464 | CTD | |
| G | LPHN3 | latrophilin 3 |
|
decreases expression | ISO | 4 | 62,362,839 | 62,938,168 | RGD:6480464 | CTD | |
| G | LPIN1 | lipin 1 |
|
increases expression | ISO | 2 | 11,817,705 | 11,967,535 | RGD:6480464 | CTD | |
| G | LPIN1 | lipin 1 |
|
decreases expression | ISO | 2 | 11,817,705 | 11,967,535 | RGD:6480464 | CTD | |
| G | LPIN2 | lipin 2 |
|
multiple interactions | ISO | 18 | 2,916,992 | 3,011,945 | RGD:6480464 | CTD | |
| G | LPIN2 | lipin 2 |
|
increases expression | ISO | 18 | 2,916,992 | 3,011,945 | RGD:6480464 | CTD | |
| G | LPIN2 | lipin 2 |
|
multiple interactions | ISO | 18 | 2,916,992 | 3,011,945 | RGD:6480464 | CTD | |
| G | LPL | lipoprotein lipase |
|
affects expression | ISO | 8 | 19,796,582 | 19,824,770 | RGD:6480464 | CTD | |
| G | LPL | lipoprotein lipase |
|
decreases expression | ISO | 8 | 19,796,582 | 19,824,770 | RGD:6480464 | CTD | |
| G | LPL | lipoprotein lipase |
|
multiple interactions | ISO | 8 | 19,796,582 | 19,824,770 | RGD:6480464 | CTD | |
| G | LPL | lipoprotein lipase |
|
increases expression | ISO | 8 | 19,796,582 | 19,824,770 | RGD:6480464 | CTD | |
| G | LPL | lipoprotein lipase |
|
multiple interactions | ISO | 8 | 19,796,582 | 19,824,770 | RGD:6480464 | CTD | |
| G | LPL | lipoprotein lipase |
|
increases expression | ISO | 8 | 19,796,582 | 19,824,770 | RGD:6480464 | CTD | |
| G | LPPR1 | lipid phosphate phosphatase-related protein type 1 |
|
multiple interactions | EXP | 9 | 103,791,031 | 104,087,417 | RGD:6480464 | CTD | |
| G | LPXN | leupaxin |
|
multiple interactions | ISO | 11 | 58,294,344 | 58,345,639 | RGD:6480464 | CTD | |
| G | LRAT | lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase) |
|
decreases expression | ISO | 4 | 155,665,163 | 155,674,270 | RGD:6480464 | CTD | |
| G | LRCH1 | leucine-rich repeats and calponin homology (CH) domain containing 1 |
|
multiple interactions | EXP | 13 | 47,127,296 | 47,327,176 | RGD:6480464 | CTD | |
| G | LRCH3 | leucine-rich repeats and calponin homology (CH) domain containing 3 |
|
multiple interactions | EXP | 3 3 |
197,518,145 197,608,988 |
197,598,456 197,615,307 |
RGD:6480464 | CTD | |
| G | LRFN3 | leucine rich repeat and fibronectin type III domain containing 3 |
|
increases expression | ISO | 19 | 36,428,022 | 36,436,097 | RGD:6480464 | CTD | |
| G | LRFN3 | leucine rich repeat and fibronectin type III domain containing 3 |
|
multiple interactions | ISO | 19 | 36,428,022 | 36,436,097 | RGD:6480464 | CTD | |
| G | LRFN3 | leucine rich repeat and fibronectin type III domain containing 3 |
|
affects expression | ISO | 19 | 36,428,022 | 36,436,097 | RGD:6480464 | CTD | |
| G | LRG1 | leucine-rich alpha-2-glycoprotein 1 |
|
increases expression | ISO | 19 | 4,537,227 | 4,540,036 | RGD:6480464 | CTD | |
| G | LRIG1 | leucine-rich repeats and immunoglobulin-like domains 1 |
|
decreases expression | ISO | 3 | 66,429,221 | 66,550,845 | RGD:6480464 | CTD | |
| G | LRMP | lymphoid-restricted membrane protein |
|
decreases expression | ISO | 12 | 25,205,181 | 25,261,269 | RGD:6480464 | CTD | |
| G | LRP1 | low density lipoprotein receptor-related protein 1 |
|
decreases expression | ISO | 12 | 57,522,282 | 57,607,142 | RGD:6480464 | CTD | |
| G | LRP1B | low density lipoprotein receptor-related protein 1B |
|
increases expression | ISO | 2 | 140,988,996 | 142,889,270 | RGD:6480464 | CTD | |
| G | LRP3 | low density lipoprotein receptor-related protein 3 |
|
decreases expression | ISO | 19 | 33,685,599 | 33,699,773 | RGD:6480464 | CTD | |
| G | LRP3 | low density lipoprotein receptor-related protein 3 |
|
affects expression | ISO | 19 | 33,685,599 | 33,699,773 | RGD:6480464 | CTD | |
| G | LRP3 | low density lipoprotein receptor-related protein 3 |
|
affects expression | ISO | 19 | 33,685,599 | 33,699,773 | RGD:6480464 | CTD | |
| G | LRP3 | low density lipoprotein receptor-related protein 3 |
|
decreases expression | ISO | 19 | 33,685,599 | 33,699,773 | RGD:6480464 | CTD | |
| G | LRP4 | low density lipoprotein receptor-related protein 4 |
|
multiple interactions | ISO | 11 | 46,878,268 | 46,940,173 | RGD:6480464 | CTD | |
| G | LRP4 | low density lipoprotein receptor-related protein 4 |
|
increases expression | ISO | 11 | 46,878,268 | 46,940,173 | RGD:6480464 | CTD | |
| G | LRP5 | low density lipoprotein receptor-related protein 5 |
|
multiple interactions | EXP | 11 | 68,080,108 | 68,216,743 | RGD:6480464 | CTD | |
| G | LRP6 | low density lipoprotein receptor-related protein 6 |
|
multiple interactions | EXP | 12 | 12,268,959 | 12,419,811 | RGD:6480464 | CTD | |
| G | LRP6 | low density lipoprotein receptor-related protein 6 |
|
increases expression | ISO | 12 | 12,268,959 | 12,419,811 | RGD:6480464 | CTD | |
| G | LRP8 | low density lipoprotein receptor-related protein 8, apolipoprotein e receptor |
|
increases expression | ISO | 1 | 53,708,036 | 53,793,821 | RGD:6480464 | CTD | |
| G | LRPPRC | leucine-rich pentatricopeptide repeat containing |
|
increases expression | ISO | 2 | 44,113,363 | 44,223,144 | RGD:6480464 | CTD | |
| G | LRR1 | leucine rich repeat protein 1 |
|
multiple interactions | ISO | 14 | 50,065,415 | 50,081,390 | RGD:6480464 | CTD | |
| G | LRR1 | leucine rich repeat protein 1 |
|
increases expression | ISO | 14 | 50,065,415 | 50,081,390 | RGD:6480464 | CTD | |
| G | LRRC16A | leucine rich repeat containing 16A |
|
increases expression | ISO | 6 | 25,279,656 | 25,620,758 | RGD:6480464 | CTD | |
| G | LRRC18 | leucine rich repeat containing 18 |
|
increases expression | ISO | 10 | 50,117,528 | 50,122,280 | RGD:6480464 | CTD | |
| G | LRRC20 | leucine rich repeat containing 20 |
|
increases expression | ISO | 10 | 72,058,729 | 72,142,382 | RGD:6480464 | CTD | |
| G | LRRC24 | leucine rich repeat containing 24 |
|
increases expression | ISO | 8 | 145,747,761 | 145,752,416 | RGD:6480464 | CTD | |
| G | LRRC3 | leucine rich repeat containing 3 |
|
decreases expression | ISO | 21 | 45,875,393 | 45,878,739 | RGD:6480464 | CTD | |
| G | LRRC3 | leucine rich repeat containing 3 |
|
multiple interactions | ISO | 21 | 45,875,393 | 45,878,739 | RGD:6480464 | CTD | |
| G | MAD2L1 | MAD2 mitotic arrest deficient-like 1 (yeast) |
|
multiple interactions | ISO | 4 | 120,980,577 | 120,988,013 | RGD:6480464 | CTD | |
| G | MAFB | v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) |
|
multiple interactions | EXP | 20 | 39,314,515 | 39,317,876 | RGD:6480464 | CTD | |
| G | MAFB | v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) |
|
decreases expression | ISO | 20 | 39,314,515 | 39,317,876 | RGD:6480464 | CTD | |
| G | MAFB | v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) |
|
increases expression | ISO | 20 | 39,314,515 | 39,317,876 | RGD:6480464 | CTD | |
| G | MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) |
|
multiple interactions | ISO | 22 | 38,597,939 | 38,612,518 | RGD:6480464 | CTD | |
| G | MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) |
|
increases expression | ISO | 22 | 38,597,939 | 38,612,518 | RGD:6480464 | CTD | |
| G | MAG | myelin associated glycoprotein |
|
affects expression | ISO | 19 | 35,782,989 | 35,804,710 | RGD:6480464 | CTD | |
| G | MAGEA9 | melanoma antigen family A, 9 |
|
increases expression | ISO | X | 148,863,600 | 148,869,399 | RGD:6480464 | CTD | |
| G | MAGEA9 | melanoma antigen family A, 9 |
|
multiple interactions | ISO | X | 148,863,600 | 148,869,399 | RGD:6480464 | CTD | |
| G | MAGED1 | melanoma antigen family D, 1 |
|
multiple interactions | EXP | X | 51,546,155 | 51,645,450 | RGD:6480464 | CTD | |
| G | MAGEL2 | MAGE-like 2 |
|
multiple interactions | ISO | 15 | 23,888,696 | 23,892,993 | RGD:6480464 | CTD | |
| G | MAGT1 | magnesium transporter 1 |
|
multiple interactions | ISO | X | 77,081,861 | 77,151,065 | RGD:6480464 | CTD | |
| G | MAL2 | mal, T-cell differentiation protein 2 (gene/pseudogene) |
|
increases expression | ISO | 8 | 120,220,610 | 120,257,913 | RGD:6480464 | CTD | |
| G | MALL | mal, T-cell differentiation protein-like |
|
decreases expression | ISO | 2 | 110,841,447 | 110,874,143 | RGD:6480464 | CTD | |
| G | MAMDC2 | MAM domain containing 2 |
|
affects expression | ISO | 9 | 72,658,497 | 72,841,888 | RGD:6480464 | CTD | |
| G | MAMDC2 | MAM domain containing 2 |
|
multiple interactions | ISO | 9 | 72,658,497 | 72,841,888 | RGD:6480464 | CTD | |
| G | MAMDC2 | MAM domain containing 2 |
|
decreases expression | ISO | 9 | 72,658,497 | 72,841,888 | RGD:6480464 | CTD | |
| G | MAML1 | mastermind-like 1 (Drosophila) |
|
multiple interactions | EXP | 5 | 179,159,851 | 179,204,287 | RGD:6480464 | CTD | |
| G | MAML2 | mastermind-like 2 (Drosophila) |
|
multiple interactions | EXP | 11 | 95,711,440 | 96,076,344 | RGD:6480464 | CTD | |
| G | MAN1A1 | mannosidase, alpha, class 1A, member 1 |
|
decreases expression | ISO | 6 | 119,498,366 | 119,670,931 | RGD:6480464 | CTD | |
| G | MAN1A1 | mannosidase, alpha, class 1A, member 1 |
|
increases expression | ISO | 6 | 119,498,366 | 119,670,931 | RGD:6480464 | CTD | |
| G | MAN1A1 | mannosidase, alpha, class 1A, member 1 |
|
decreases expression | ISO | 6 | 119,498,366 | 119,670,931 | RGD:6480464 | CTD | |
| G | MAN2A1 | mannosidase, alpha, class 2A, member 1 |
|
multiple interactions | EXP | 5 | 109,025,156 | 109,203,429 | RGD:6480464 | CTD | |
| G | MAN2B1 | mannosidase, alpha, class 2B, member 1 |
|
affects expression | ISO | 19 | 12,757,322 | 12,777,591 | RGD:6480464 | CTD | |
| G | MAN2B2 | mannosidase, alpha, class 2B, member 2 |
|
multiple interactions | EXP | 4 | 6,576,902 | 6,624,188 | RGD:6480464 | CTD | |
| G | MAN2B2 | mannosidase, alpha, class 2B, member 2 |
|
increases expression | ISO | 4 | 6,576,902 | 6,624,188 | RGD:6480464 | CTD | |
| G | MANBA | mannosidase, beta A, lysosomal |
|
decreases expression | ISO | 4 | 103,552,643 | 103,682,151 | RGD:6480464 | CTD | |
| G | MANBA | mannosidase, beta A, lysosomal |
|
increases expression | ISO | 4 | 103,552,643 | 103,682,151 | RGD:6480464 | CTD | |
| G | MANBAL | mannosidase, beta A, lysosomal-like |
|
multiple interactions | ISO | 20 | 35,918,051 | 35,945,663 | RGD:6480464 | CTD | |
| G | MANEA | mannosidase, endo-alpha |
|
increases expression | ISO | 6 | 96,025,373 | 96,057,328 | RGD:6480464 | CTD | |
| G | MANF | mesencephalic astrocyte-derived neurotrophic factor |
|
multiple interactions | ISO | 3 | 51,422,692 | 51,426,828 | RGD:6480464 | CTD | |
| G | MAOA | monoamine oxidase A |
|
affects expression | ISO | X | 43,514,155 | 43,606,071 | RGD:6480464 | CTD | |
| G | MAOA | monoamine oxidase A |
|
increases expression | ISO | X | 43,514,155 | 43,606,071 | RGD:6480464 | CTD | |
| G | MAOA | monoamine oxidase A |
|
increases expression | ISO | X | 43,514,155 | 43,606,071 | RGD:6480464 | CTD | |
| G | MAOB | monoamine oxidase B |
|
decreases expression | ISO | X | 43,625,857 | 43,741,721 | RGD:6480464 | CTD | |
| G | MAP1A | microtubule-associated protein 1A |
|
increases expression | ISO | 15 | 43,809,806 | 43,823,818 | RGD:6480464 | CTD | |
| G | MAP1LC3A | microtubule-associated protein 1 light chain 3 alpha |
|
increases expression | ISO | 20 | 33,134,688 | 33,148,149 | RGD:6480464 | CTD | |
| G | MAP1LC3B | microtubule-associated protein 1 light chain 3 beta |
|
increases expression | ISO | 16 | 87,425,801 | 87,438,380 | RGD:6480464 | CTD | |
| G | MAP2K2 | mitogen-activated protein kinase kinase 2 |
|
multiple interactions | ISO | 19 | 4,090,319 | 4,124,126 | RGD:6480464 | CTD | |
| G | MAP2K2 | mitogen-activated protein kinase kinase 2 |
|
affects expression | ISO | 19 | 4,090,319 | 4,124,126 | RGD:6480464 | CTD | |
| G | MAP2K3 | mitogen-activated protein kinase kinase 3 |
|
decreases expression | ISO | 17 | 21,187,968 | 21,218,552 | RGD:6480464 | CTD | |
| G | MAP2K5 | mitogen-activated protein kinase kinase 5 |
|
multiple interactions | ISO | 15 | 67,835,021 | 68,099,455 | RGD:6480464 | CTD | |
| G | MAP2K6 | mitogen-activated protein kinase kinase 6 |
|
multiple interactions | ISO | 17 | 67,410,838 | 67,538,470 | RGD:6480464 | CTD | |
| G | MAP2K6 | mitogen-activated protein kinase kinase 6 |
|
decreases expression | ISO | 17 | 67,410,838 | 67,538,470 | RGD:6480464 | CTD | |
| G | MAP3K13 | mitogen-activated protein kinase kinase kinase 13 |
|
increases expression | ISO | 3 | 185,000,729 | 185,206,882 | RGD:6480464 | CTD | |
| G | MAP3K13 | mitogen-activated protein kinase kinase kinase 13 |
|
multiple interactions | ISO | 3 | 185,000,729 | 185,206,882 | RGD:6480464 | CTD | |
| G | MAP3K14 | mitogen-activated protein kinase kinase kinase 14 |
|
multiple interactions | EXP | 17 | 43,340,488 | 43,394,414 | RGD:6480464 | CTD | |
| G | MAP3K14 | mitogen-activated protein kinase kinase kinase 14 |
|
affects expression | ISO | 17 | 43,340,488 | 43,394,414 | RGD:6480464 | CTD | |
| G | MAP3K14 | mitogen-activated protein kinase kinase kinase 14 |
|
decreases expression | ISO | 17 | 43,340,488 | 43,394,414 | RGD:6480464 | CTD | |
| G | MAP3K2 | mitogen-activated protein kinase kinase kinase 2 |
|
decreases expression | ISO | 2 | 128,056,245 | 128,100,805 | RGD:6480464 | CTD | |
| G | MAP3K3 | mitogen-activated protein kinase kinase kinase 3 |
|
multiple interactions | EXP | 17 | 61,699,801 | 61,773,670 | RGD:6480464 | CTD | |
| G | MAP3K4 | mitogen-activated protein kinase kinase kinase 4 |
|
multiple interactions | ISO | 6 | 161,412,822 | 161,538,417 | RGD:6480464 | CTD | |
| G | MAP3K5 | mitogen-activated protein kinase kinase kinase 5 |
|
increases expression | ISO | 6 | 136,878,187 | 137,113,656 | RGD:6480464 | CTD | |
| G | MAP3K6 | mitogen-activated protein kinase kinase kinase 6 |
|
increases expression | ISO | 1 | 27,681,670 | 27,693,337 | RGD:6480464 | CTD | |
| G | MAP3K7 | mitogen-activated protein kinase kinase kinase 7 |
|
increases expression | ISO | 6 | 91,223,292 | 91,297,020 | RGD:6480464 | CTD | |
| G | MAP3K7 | mitogen-activated protein kinase kinase kinase 7 |
|
decreases expression | ISO | 6 | 91,223,292 | 91,297,020 | RGD:6480464 | CTD | |
| G | MAP3K8 | mitogen-activated protein kinase kinase kinase 8 |
|
multiple interactions | EXP | 10 | 30,722,950 | 30,750,762 | RGD:6480464 | CTD | |
| G | MAP4 | microtubule-associated protein 4 |
|
decreases expression | ISO | 3 | 47,892,180 | 48,130,769 | RGD:6480464 | CTD | |
| G | MAP7 | microtubule-associated protein 7 |
|
increases expression | ISO | 6 | 136,663,419 | 136,871,957 | RGD:6480464 | CTD | |
| G | MAP9 | microtubule-associated protein 9 |
|
increases expression | ISO | 4 | 156,263,810 | 156,298,122 | RGD:6480464 | CTD | |
| G | MARVELD3 | MARVEL domain containing 3 |
|
increases expression | ISO | 16 | 71,660,056 | 71,675,868 | RGD:6480464 | CTD | |
| G | MBOAT7 | membrane bound O-acyltransferase domain containing 7 |
|
increases expression | ISO | 19 | 54,677,106 | 54,693,733 | RGD:6480464 | CTD | |
| G | MBOAT7 | membrane bound O-acyltransferase domain containing 7 |
|
increases expression | ISO | 19 | 54,677,106 | 54,693,733 | RGD:6480464 | CTD | |
| G | MC1R | melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) |
|
decreases expression | ISO | 16 | 89,984,287 | 89,987,385 | RGD:6480464 | CTD | |
| G | MC1R | melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) |
|
multiple interactions | ISO | 16 | 89,984,287 | 89,987,385 | RGD:6480464 | CTD | |
| G | MCAM | melanoma cell adhesion molecule |
|
multiple interactions | EXP | 11 | 119,179,234 | 119,187,840 | RGD:6480464 | CTD | |
| G | MCAT | malonyl CoA:ACP acyltransferase (mitochondrial) |
|
multiple interactions | ISO | 22 | 43,528,212 | 43,539,403 | RGD:6480464 | CTD | |
| G | MCCC2 | methylcrotonoyl-CoA carboxylase 2 (beta) |
|
multiple interactions | EXP | 5 | 70,883,115 | 70,954,531 | RGD:6480464 | CTD | |
| G | MCCC2 | methylcrotonoyl-CoA carboxylase 2 (beta) |
|
multiple interactions | ISO | 5 | 70,883,115 | 70,954,531 | RGD:6480464 | CTD | |
| G | MCCC2 | methylcrotonoyl-CoA carboxylase 2 (beta) |
|
increases expression | ISO | 5 | 70,883,115 | 70,954,531 | RGD:6480464 | CTD | |
| G | MCHR1 | melanin-concentrating hormone receptor 1 |
|
multiple interactions | EXP | 22 | 41,075,182 | 41,078,818 | RGD:6480464 | CTD | |
| G | MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) |
|
multiple interactions | EXP | 1 | 150,547,027 | 150,552,214 | RGD:6480464 | CTD | |
| G | MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) |
|
decreases expression | ISO | 1 | 150,547,027 | 150,552,214 | RGD:6480464 | CTD | |
| G | MCM10 | minichromosome maintenance complex component 10 |
|
multiple interactions | ISO | 10 | 13,203,554 | 13,253,104 | RGD:6480464 | CTD | |
| G | MCM10 | minichromosome maintenance complex component 10 |
|
decreases expression | ISO | 10 | 13,203,554 | 13,253,104 | RGD:6480464 | CTD | |
| G | MCM2 | minichromosome maintenance complex component 2 |
|
multiple interactions | ISO | 3 | 127,317,253 | 127,341,279 | RGD:6480464 | CTD | |
| G | MCM2 | minichromosome maintenance complex component 2 |
|
increases expression | ISO | 3 | 127,317,253 | 127,341,279 | RGD:6480464 | CTD | |
| G | MCM2 | minichromosome maintenance complex component 2 |
|
multiple interactions | ISO | 3 | 127,317,253 | 127,341,279 | RGD:6480464 | CTD | |
| G | MCM3 | minichromosome maintenance complex component 3 |
|
affects expression | ISO | 6 | 52,128,812 | 52,149,679 | RGD:6480464 | CTD | |
| G | MCM3 | minichromosome maintenance complex component 3 |
|
increases expression | ISO | 6 | 52,128,812 | 52,149,679 | RGD:6480464 | CTD | |
| G | MCM3 | minichromosome maintenance complex component 3 |
|
multiple interactions | ISO | 6 | 52,128,812 | 52,149,679 | RGD:6480464 | CTD | |
| G | MCM4 | minichromosome maintenance complex component 4 |
|
multiple interactions | EXP | 8 | 48,872,763 | 48,890,720 | RGD:6480464 | CTD | |
| G | MCM4 | minichromosome maintenance complex component 4 |
|
increases expression | ISO | 8 | 48,872,763 | 48,890,720 | RGD:6480464 | CTD | |
| G | MCM4 | minichromosome maintenance complex component 4 |
|
multiple interactions | ISO | 8 | 48,872,763 | 48,890,720 | RGD:6480464 | CTD | |
| G | MCM5 | minichromosome maintenance complex component 5 |
|
increases expression | ISO | 22 | 35,796,116 | 35,820,495 | RGD:6480464 | CTD | |
| G | MCM5 | minichromosome maintenance complex component 5 |
|
multiple interactions | ISO | 22 | 35,796,116 | 35,820,495 | RGD:6480464 | CTD | |
| G | MCM5 | minichromosome maintenance complex component 5 |
|
multiple interactions | ISO | 22 | 35,796,116 | 35,820,495 | RGD:6480464 | CTD | |
| G | MCM5 | minichromosome maintenance complex component 5 |
|
increases expression | ISO | 22 | 35,796,116 | 35,820,495 | RGD:6480464 | CTD | |
| G | MCM6 | minichromosome maintenance complex component 6 |
|
increases expression | ISO | 2 | 136,597,196 | 136,634,047 | RGD:6480464 | CTD | |
| G | MCM6 | minichromosome maintenance complex component 6 |
|
increases expression | ISO | 2 | 136,597,196 | 136,634,047 | RGD:6480464 | CTD | |
| G | MCM6 | minichromosome maintenance complex component 6 |
|
multiple interactions | ISO | 2 | 136,597,196 | 136,634,047 | RGD:6480464 | CTD | |
| G | MCM7 | minichromosome maintenance complex component 7 |
|
multiple interactions | ISO | 7 | 99,690,404 | 99,699,427 | RGD:6480464 | CTD | |
| G | MCM7 | minichromosome maintenance complex component 7 |
|
increases expression | ISO | 7 | 99,690,404 | 99,699,427 | RGD:6480464 | CTD | |
| G | MCM7 | minichromosome maintenance complex component 7 |
|
multiple interactions | ISO | 7 | 99,690,404 | 99,699,427 | RGD:6480464 | CTD | |
| G | MCM8 | minichromosome maintenance complex component 8 |
|
multiple interactions | ISO | 20 | 5,931,298 | 5,975,833 | RGD:6480464 | CTD | |
| G | MCM8 | minichromosome maintenance complex component 8 |
|
increases expression | ISO | 20 | 5,931,298 | 5,975,833 | RGD:6480464 | CTD | |
| G | MCM8 | minichromosome maintenance complex component 8 |
|
multiple interactions | ISO | 20 | 5,931,298 | 5,975,833 | RGD:6480464 | CTD | |
| G | MCOLN1 | mucolipin 1 |
|
increases expression | ISO | 19 | 7,587,496 | 7,598,895 | RGD:6480464 | CTD | |
| G | MCOLN2 | mucolipin 2 |
|
increases expression | ISO | 1 | 85,391,266 | 85,462,796 | RGD:6480464 | CTD | |
| G | MCOLN2 | mucolipin 2 |
|
decreases expression | ISO | 1 | 85,391,266 | 85,462,796 | RGD:6480464 | CTD | |
| G | MCRS1 | microspherule protein 1 |
|
decreases expression | ISO | 12 | 49,952,085 | 49,961,911 | RGD:6480464 | CTD | |
| G | MCRS1 | microspherule protein 1 |
|
multiple interactions | ISO | 12 | 49,952,085 | 49,961,911 | RGD:6480464 | CTD | |
| G | MCTP1 | multiple C2 domains, transmembrane 1 |
|
increases expression | ISO | 5 | 94,042,284 | 94,620,279 | RGD:6480464 | CTD | |
| G | MDC1 | mediator of DNA-damage checkpoint 1 |
|
multiple interactions | EXP | 6 | 30,667,584 | 30,685,458 | RGD:6480464 | CTD | |
| G | MDFIC | MyoD family inhibitor domain containing |
|
increases expression | ISO | 7 | 114,562,209 | 114,659,970 | RGD:6480464 | CTD | |
| G | MDFIC | MyoD family inhibitor domain containing |
|
multiple interactions | ISO | 7 | 114,562,209 | 114,659,970 | RGD:6480464 | CTD | |
| G | MDFIC | MyoD family inhibitor domain containing |
|
increases expression | ISO | 7 | 114,562,209 | 114,659,970 | RGD:6480464 | CTD | |
| G | MDH1B | malate dehydrogenase 1B, NAD (soluble) |
|
multiple interactions | ISO | 2 | 207,602,487 | 207,630,050 | RGD:6480464 | CTD | |
| G | MDH2 | malate dehydrogenase 2, NAD (mitochondrial) |
|
increases expression | ISO | 7 | 75,677,393 | 75,695,931 | RGD:6480464 | CTD | |
| G | MDM2 | MDM2 oncogene, E3 ubiquitin protein ligase |
|
multiple interactions | ISO | 12 | 69,201,971 | 69,239,320 | RGD:6480464 | CTD | |
| G | MDM2 | MDM2 oncogene, E3 ubiquitin protein ligase |
|
increases expression | ISO | 12 | 69,201,971 | 69,239,320 | RGD:6480464 | CTD | |
| G | MDM4 | Mdm4 p53 binding protein homolog (mouse) |
|
decreases expression | ISO | 1 | 204,485,507 | 204,527,248 | RGD:6480464 | CTD | |
| G | MDN1 | MDN1, midasin homolog (yeast) |
|
increases expression | ISO | 6 | 90,353,231 | 90,529,442 | RGD:6480464 | CTD | |
| G | MDN1 | MDN1, midasin homolog (yeast) |
|
multiple interactions | ISO | 6 | 90,353,231 | 90,529,442 | RGD:6480464 | CTD | |
| G | MGST3 | microsomal glutathione S-transferase 3 |
|
multiple interactions | ISO | 1 | 165,600,110 | 165,625,373 | RGD:6480464 | CTD | |
| G | MGST3 | microsomal glutathione S-transferase 3 |
|
increases expression | ISO | 1 | 165,600,110 | 165,625,373 | RGD:6480464 | CTD | |
| G | MIA | melanoma inhibitory activity |
|
increases expression | ISO | 19 | 41,281,082 | 41,283,398 | RGD:6480464 | CTD | |
| G | MIA2 | melanoma inhibitory activity 2 |
|
multiple interactions | ISO | 14 | 39,703,125 | 39,722,575 | RGD:6480464 | CTD | |
| G | MIB2 | mindbomb E3 ubiquitin protein ligase 2 |
|
multiple interactions | EXP | 1 | 1,550,795 | 1,565,990 | RGD:6480464 | CTD | |
| G | MICAL1 | microtubule associated monooxygenase, calponin and LIM domain containing 1 |
|
decreases expression | ISO | 6 | 109,765,265 | 109,777,190 | RGD:6480464 | CTD | |
| G | MICAL2 | microtubule associated monooxygenase, calponin and LIM domain containing 2 |
|
multiple interactions | EXP | 11 | 12,132,138 | 12,285,332 | RGD:6480464 | CTD | |
| G | MICU1 | mitochondrial calcium uptake 1 |
|
increases expression | ISO | 10 | 74,127,084 | 74,385,949 | RGD:6480464 | CTD | |
| G | MID1IP1 | MID1 interacting protein 1 |
|
multiple interactions | EXP | X | 38,660,685 | 38,665,785 | RGD:6480464 | CTD | |
| G | MID1IP1 | MID1 interacting protein 1 |
|
decreases expression | ISO | X | 38,660,685 | 38,665,785 | RGD:6480464 | CTD | |
| G | MIDN | midnolin |
|
increases expression | ISO | 19 | 1,248,552 | 1,259,142 | RGD:6480464 | CTD | |
| G | MIIP | migration and invasion inhibitory protein |
|
multiple interactions | ISO | 1 | 12,079,299 | 12,092,106 | RGD:6480464 | CTD | |
| G | MINOS1 | mitochondrial inner membrane organizing system 1 |
|
increases expression | ISO | 1 | 19,923,471 | 19,956,315 | RGD:6480464 | CTD | |
| G | MIP | major intrinsic protein of lens fiber |
|
decreases expression | ISO | 12 | 56,843,286 | 56,848,435 | RGD:6480464 | CTD | |
| G | MIP | major intrinsic protein of lens fiber |
|
multiple interactions | ISO | 12 | 56,843,286 | 56,848,435 | RGD:6480464 | CTD | |
| G | MITD1 | MIT, microtubule interacting and transport, domain containing 1 |
|
decreases expression | ISO | 2 | 99,785,726 | 99,797,492 | RGD:6480464 | CTD | |
| G | MITF | microphthalmia-associated transcription factor |
|
multiple interactions | EXP | 3 | 69,788,586 | 70,017,488 | RGD:6480464 | CTD | |
| G | MKI67 | antigen identified by monoclonal antibody Ki-67 |
|
increases expression | ISO | 10 | 129,894,923 | 129,924,468 | RGD:6480464 | CTD | |
| G | MKI67 | antigen identified by monoclonal antibody Ki-67 |
|
multiple interactions | ISO | 10 | 129,894,923 | 129,924,468 | RGD:6480464 | CTD | |
| G | MKI67IP | MKI67 (FHA domain) interacting nucleolar phosphoprotein |
|
increases expression | ISO | 2 | 122,484,521 | 122,494,503 | RGD:6480464 | CTD | |
| G | MKL2 | MKL/myocardin-like 2 |
|
affects expression | ISO | 16 | 14,165,196 | 14,360,630 | RGD:6480464 | CTD | |
| G | MKLN1 | muskelin 1, intracellular mediator containing kelch motifs |
|
increases expression | ISO | 7 | 130,794,855 | 131,181,398 | RGD:6480464 | CTD | |
| G | MKLN1 | muskelin 1, intracellular mediator containing kelch motifs |
|
decreases expression | ISO | 7 | 130,794,855 | 131,181,398 | RGD:6480464 | CTD | |
| G | MLANA | melan-A |
|
multiple interactions | ISO | 9 | 5,890,909 | 5,909,822 | RGD:6480464 | CTD | |
| G | MLEC | malectin |
|
affects expression | ISO | 12 | 121,124,949 | 121,139,667 | RGD:6480464 | CTD | |
| G | MLF1 | myeloid leukemia factor 1 |
|
increases expression | ISO | 3 | 158,288,953 | 158,324,249 | RGD:6480464 | CTD | |
| G | MLH1 | mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
|
increases expression | ISO | 3 | 37,034,841 | 37,092,337 | RGD:6480464 | CTD | |
| G | MLH3 | mutL homolog 3 (E. coli) |
|
multiple interactions | EXP | 14 | 75,480,467 | 75,518,235 | RGD:6480464 | CTD | |
| G | MLLT11 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11 |
|
multiple interactions | EXP | 1 | 151,032,151 | 151,040,973 | RGD:6480464 | CTD | |
| G | MLLT11 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11 |
|
multiple interactions | ISO | 1 | 151,032,151 | 151,040,973 | RGD:6480464 | CTD | |
| G | MLLT11 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11 |
|
increases expression | ISO | 1 | 151,032,151 | 151,040,973 | RGD:6480464 | CTD | |
| G | MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 |
|
multiple interactions | ISO | 6 | 168,227,671 | 168,372,700 | RGD:6480464 | CTD | |
| G | MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 |
|
increases expression | ISO | 6 | 168,227,671 | 168,372,700 | RGD:6480464 | CTD | |
| G | MLX | MLX, MAX dimerization protein |
|
increases expression | ISO | 17 | 40,719,078 | 40,725,221 | RGD:6480464 | CTD | |
| G | MLX | MLX, MAX dimerization protein |
|
multiple interactions | ISO | 17 | 40,719,078 | 40,725,221 | RGD:6480464 | CTD | |
| G | MLXIPL | MLX interacting protein-like |
|
multiple interactions | ISO | 7 | 73,007,524 | 73,038,870 | RGD:6480464 | CTD | |
| G | MLXIPL | MLX interacting protein-like |
|
decreases expression | ISO | 7 | 73,007,524 | 73,038,870 | RGD:6480464 | CTD | |
| G | MLXIPL | MLX interacting protein-like |
|
multiple interactions | ISO | 7 | 73,007,524 | 73,038,870 | RGD:6480464 | CTD | |
| G | MLYCD | malonyl-CoA decarboxylase |
|
increases expression | ISO | 16 | 83,932,730 | 83,949,787 | RGD:6480464 | CTD | |
| G | MLYCD | malonyl-CoA decarboxylase |
|
multiple interactions | ISO | 16 | 83,932,730 | 83,949,787 | RGD:6480464 | CTD | |
| G | MLYCD | malonyl-CoA decarboxylase |
|
multiple interactions | ISO | 16 | 83,932,730 | 83,949,787 | RGD:6480464 | CTD | |
| G | MMAB | methylmalonic aciduria (cobalamin deficiency) cblB type |
|
decreases expression | ISO | 12 | 109,991,520 | 110,011,358 | RGD:6480464 | CTD | |
| G | MMACHC | methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria |
|
multiple interactions | EXP | 1 | 45,965,856 | 45,976,739 | RGD:6480464 | CTD | |
| G | MMADHC | methylmalonic aciduria (cobalamin deficiency) cblD type, with homocystinuria |
|
increases expression | ISO | 2 | 150,426,147 | 150,444,330 | RGD:6480464 | CTD | |
| G | MMADHC | methylmalonic aciduria (cobalamin deficiency) cblD type, with homocystinuria |
|
increases expression | ISO | 2 | 150,426,147 | 150,444,330 | RGD:6480464 | CTD | |
| G | MMD | monocyte to macrophage differentiation-associated |
|
increases expression | ISO | 17 | 53,469,974 | 53,499,341 | RGD:6480464 | CTD | |
| G | MMP11 | matrix metallopeptidase 11 (stromelysin 3) |
|
increases expression | ISO | 22 | 24,115,036 | 24,126,503 | RGD:6480464 | CTD | |
| G | MMP14 | matrix metallopeptidase 14 (membrane-inserted) |
|
decreases expression | ISO | 14 | 23,305,793 | 23,316,803 | RGD:6480464 | CTD | |
| G | MMP16 | matrix metallopeptidase 16 (membrane-inserted) |
|
decreases expression | ISO | 8 | 89,049,460 | 89,339,717 | RGD:6480464 | CTD | |
| G | MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) |
|
multiple interactions | EXP | 11 | 102,706,528 | 102,714,342 | RGD:6480464 | CTD | |
| G | MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) |
|
decreases expression | ISO | 11 | 102,391,239 | 102,401,478 | RGD:6480464 | CTD | |
| G | MMP8 | matrix metallopeptidase 8 (neutrophil collagenase) |
|
multiple interactions | ISO | 11 | 102,582,526 | 102,595,685 | RGD:6480464 | CTD | |
| G | MMS22L | MMS22-like, DNA repair protein |
|
multiple interactions | ISO | 6 | 97,590,037 | 97,731,052 | RGD:6480464 | CTD | |
| G | MRO | maestro |
|
affects expression | ISO | 18 | 48,321,490 | 48,351,754 | RGD:6480464 | CTD | |
| G | MRPL46 | mitochondrial ribosomal protein L46 |
|
multiple interactions | EXP | 15 | 89,002,709 | 89,010,633 | RGD:6480464 | CTD | |
| G | MRPL50 | mitochondrial ribosomal protein L50 |
|
decreases expression | ISO | 9 | 104,152,249 | 104,160,919 | RGD:6480464 | CTD | |
| G | MRPL54 | mitochondrial ribosomal protein L54 |
|
increases expression | ISO | 19 | 3,762,665 | 3,767,563 | RGD:6480464 | CTD | |
| G | MRPL9 | mitochondrial ribosomal protein L9 |
|
affects expression | ISO | 1 | 151,732,123 | 151,736,040 | RGD:6480464 | CTD | |
| G | MRPS22 | mitochondrial ribosomal protein S22 |
|
decreases expression | ISO | 3 | 139,062,861 | 139,075,888 | RGD:6480464 | CTD | |
| G | MRPS25 | mitochondrial ribosomal protein S25 |
|
decreases expression | ISO | 3 | 15,090,019 | 15,106,816 | RGD:6480464 | CTD | |
| G | MRPS28 | mitochondrial ribosomal protein S28 |
|
increases expression | ISO | 8 | 80,831,095 | 80,942,506 | RGD:6480464 | CTD | |
| G | MRPS36 | mitochondrial ribosomal protein S36 |
|
increases expression | ISO | 5 | 68,513,573 | 68,525,985 | RGD:6480464 | CTD | |
| G | MRPS36 | mitochondrial ribosomal protein S36 |
|
increases expression | ISO | 5 | 68,513,573 | 68,525,985 | RGD:6480464 | CTD | |
| G | MRPS6 | mitochondrial ribosomal protein S6 |
|
increases expression | ISO | 21 | 35,445,823 | 35,515,334 | RGD:6480464 | CTD | |
| G | MRPS6 | mitochondrial ribosomal protein S6 |
|
increases phosphorylation | ISO | 21 | 35,445,823 | 35,515,334 | RGD:6480464 | CTD | |
| G | MRPS9 | mitochondrial ribosomal protein S9 |
|
increases expression | ISO | 2 | 105,654,483 | 105,716,418 | RGD:6480464 | CTD | |
| G | MRTO4 | mRNA turnover 4 homolog (S. cerevisiae) |
|
increases expression | ISO | 1 | 19,578,075 | 19,586,622 | RGD:6480464 | CTD | |
| G | MRTO4 | mRNA turnover 4 homolog (S. cerevisiae) |
|
increases expression | ISO | 1 | 19,578,075 | 19,586,622 | RGD:6480464 | CTD | |
| G | MS4A1 | membrane-spanning 4-domains, subfamily A, member 1 |
|
decreases expression | ISO | 11 | 60,223,282 | 60,238,225 | RGD:6480464 | CTD | |
| G | MS4A15 | membrane-spanning 4-domains, subfamily A, member 15 |
|
multiple interactions | ISO | 11 | 60,524,340 | 60,544,204 | RGD:6480464 | CTD | |
| G | MS4A6A | membrane-spanning 4-domains, subfamily A, member 6A |
|
multiple interactions | ISO | 11 | 59,939,080 | 59,952,139 | RGD:6480464 | CTD | |
| G | MS4A8 | membrane-spanning 4-domains, subfamily A, member 8 |
|
decreases expression | ISO | 11 | 60,467,047 | 60,483,284 | RGD:6480464 | CTD | |
| G | MSH2 | mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli) |
|
multiple interactions | ISO | 2 | 47,630,206 | 47,710,367 | RGD:6480464 | CTD | |
| G | MSH5 | mutS homolog 5 (E. coli) |
|
multiple interactions | EXP | 6 | 31,707,725 | 31,730,455 | RGD:6480464 | CTD | |
| G | MSH6 | mutS homolog 6 (E. coli) |
|
decreases expression | ISO | 2 | 48,010,221 | 48,034,092 | RGD:6480464 | CTD | |
| G | MSI2 | musashi RNA-binding protein 2 |
|
increases expression | ISO | 17 | 55,333,931 | 55,757,299 | RGD:6480464 | CTD | |
| G | MSL2 | male-specific lethal 2 homolog (Drosophila) |
|
increases expression | ISO | 3 | 135,867,760 | 135,914,688 | RGD:6480464 | CTD | |
| G | MSMO1 | methylsterol monooxygenase 1 |
|
multiple interactions | ISO | 4 | 166,248,818 | 166,264,316 | RGD:6480464 | CTD | |
| G | MSMO1 | methylsterol monooxygenase 1 |
|
decreases expression | ISO | 4 | 166,248,818 | 166,264,316 | RGD:6480464 | CTD | |
| G | MSMO1 | methylsterol monooxygenase 1 |
|
increases expression | ISO | 4 | 166,248,818 | 166,264,316 | RGD:6480464 | CTD | |
| G | MSRB2 | methionine sulfoxide reductase B2 |
|
increases expression | ISO | 10 | 23,384,427 | 23,410,942 | RGD:6480464 | CTD | |
| G | MST1R | macrophage stimulating 1 receptor (c-met-related tyrosine kinase) |
|
multiple interactions | EXP | 3 | 49,924,435 | 49,941,306 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
affects expression | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
multiple interactions | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
decreases expression | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
multiple interactions | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
increases expression | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
decreases expression | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
affects expression | ISO | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
decreases expression | ISO | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
multiple interactions | ISO | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
increases expression | ISO | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
multiple interactions | ISO | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
decreases expression | ISO | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT4 | metallothionein 4 |
|
multiple interactions | ISO | 16 | 56,598,961 | 56,602,869 | RGD:6480464 | CTD | |
| G | MTAP | methylthioadenosine phosphorylase |
|
increases expression | ISO | 9 | 21,802,635 | 21,865,970 | RGD:6480464 | CTD | |
| G | MTCH2 | mitochondrial carrier 2 |
|
increases expression | ISO | 11 | 47,638,858 | 47,664,206 | RGD:6480464 | CTD | |
| G | MTCP1 | mature T-cell proliferation 1 |
|
multiple interactions | EXP | X | 154,292,309 | 154,299,547 | RGD:6480464 | CTD | |
| G | MTCP1 | mature T-cell proliferation 1 |
|
decreases expression | ISO | X | 154,292,309 | 154,299,547 | RGD:6480464 | CTD | |
| G | MTERFD2 | MTERF domain containing 2 |
|
increases expression | ISO | 2 | 242,026,509 | 242,041,747 | RGD:6480464 | CTD | |
| G | MTFR1 | mitochondrial fission regulator 1 |
|
increases expression | ISO | 8 | 66,556,888 | 66,622,798 | RGD:6480464 | CTD | |
| G | MTHFD1 | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase |
|
decreases expression | ISO | 14 | 64,854,759 | 64,926,725 | RGD:6480464 | CTD | |
| G | MTHFD2 | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
|
multiple interactions | EXP | 2 | 74,425,690 | 74,442,425 | RGD:6480464 | CTD | |
| G | MTHFD2 | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
|
decreases expression | ISO | 2 | 74,425,690 | 74,442,425 | RGD:6480464 | CTD | |
| G | MTHFD2 | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
|
multiple interactions | ISO | 2 | 74,425,690 | 74,442,425 | RGD:6480464 | CTD | |
| G | MTHFD2L | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like |
|
multiple interactions | EXP | 4 | 75,023,829 | 75,168,816 | RGD:6480464 | CTD | |
| G | MTHFD2L | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like |
|
decreases expression | ISO | 4 | 75,023,829 | 75,168,816 | RGD:6480464 | CTD | |
| G | MTHFR | methylenetetrahydrofolate reductase (NAD(P)H) |
|
increases expression | ISO | 1 | 11,845,787 | 11,866,160 | RGD:6480464 | CTD | |
| G | MTHFS | 5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase) |
|
increases expression | ISO | 15 | 80,135,889 | 80,189,627 | RGD:6480464 | CTD | |
| G | MUT | methylmalonyl CoA mutase |
|
affects expression | ISO | 6 | 49,398,073 | 49,431,041 | RGD:6480464 | CTD | |
| G | MYH2 | myosin, heavy chain 2, skeletal muscle, adult |
|
increases expression | ISO | 17 | 10,424,465 | 10,453,017 | RGD:6480464 | CTD | |
| G | MYH4 | myosin, heavy chain 4, skeletal muscle |
|
increases expression | ISO | 17 | 10,346,607 | 10,372,876 | RGD:6480464 | CTD | |
| G | MYH8 | myosin, heavy chain 8, skeletal muscle, perinatal |
|
increases expression | ISO | 17 | 10,293,642 | 10,325,267 | RGD:6480464 | CTD | |
| G | MYH9 | myosin, heavy chain 9, non-muscle |
|
decreases expression | ISO | 22 | 36,677,323 | 36,784,063 | RGD:6480464 | CTD | |
| G | MYL2 | myosin, light chain 2, regulatory, cardiac, slow |
|
increases expression | ISO | 12 | 111,348,623 | 111,358,404 | RGD:6480464 | CTD | |
| G | MYL6B | myosin, light chain 6B, alkali, smooth muscle and non-muscle |
|
affects expression | ISO | 12 | 56,546,204 | 56,551,771 | RGD:6480464 | CTD | |
| G | MYLK | myosin light chain kinase |
|
multiple interactions | ISO | 3 | 123,331,143 | 123,603,149 | RGD:6480464 | CTD | |
| G | MYO10 | myosin X |
|
decreases expression | ISO | 5 | 16,662,016 | 16,936,385 | RGD:6480464 | CTD | |
| G | MYO1B | myosin IB |
|
multiple interactions | ISO | 2 | 192,110,107 | 192,290,115 | RGD:6480464 | CTD | |
| G | MYO1B | myosin IB |
|
decreases expression | ISO | 2 | 192,110,107 | 192,290,115 | RGD:6480464 | CTD | |
| G | MYO1B | myosin IB |
|
decreases expression | ISO | 2 | 192,110,107 | 192,290,115 | RGD:6480464 | CTD | |
| G | MYO1B | myosin IB |
|
multiple interactions | ISO | 2 | 192,110,107 | 192,290,115 | RGD:6480464 | CTD | |
| G | MYO1C | myosin IC |
|
decreases expression | ISO | 17 | 1,367,480 | 1,396,001 | RGD:6480464 | CTD | |
| G | MYO1C | myosin IC |
|
increases expression | ISO | 17 | 1,367,480 | 1,396,001 | RGD:6480464 | CTD | |
| G | MYO1C | myosin IC |
|
increases expression | ISO | 17 | 1,367,480 | 1,396,001 | RGD:6480464 | CTD | |
| G | MYO1D | myosin ID |
|
multiple interactions | EXP | 17 | 30,819,628 | 31,203,902 | RGD:6480464 | CTD | |
| G | MYO1D | myosin ID |
|
increases expression | ISO | 17 | 30,819,628 | 31,203,902 | RGD:6480464 | CTD | |
| G | MYO1D | myosin ID |
|
affects expression | ISO | 17 | 30,819,628 | 31,203,902 | RGD:6480464 | CTD | |
| G | MYO1G | myosin IG |
|
decreases expression | ISO | 7 | 45,002,260 | 45,018,704 | RGD:6480464 | CTD | |
| G | MYO1H | myosin IH |
|
multiple interactions | ISO | 12 | 109,826,524 | 109,886,176 | RGD:6480464 | CTD | |
| G | MYO1H | myosin IH |
|
decreases expression | ISO | 12 | 109,826,524 | 109,886,176 | RGD:6480464 | CTD | |
| G | MYO5A | myosin VA (heavy chain 12, myoxin) |
|
multiple interactions | ISO | 15 | 52,599,480 | 52,821,247 | RGD:6480464 | CTD | |
| G | MYO5B | myosin VB |
|
multiple interactions | ISO | 18 | 47,349,156 | 47,721,451 | RGD:6480464 | CTD | |
| G | MYO5B | myosin VB |
|
increases expression | ISO | 18 | 47,349,156 | 47,721,451 | RGD:6480464 | CTD | |
| G | MYO5B | myosin VB |
|
increases expression | ISO | 18 | 47,349,156 | 47,721,451 | RGD:6480464 | CTD | |
| G | MYO5B | myosin VB |
|
multiple interactions | ISO | 18 | 47,349,156 | 47,721,451 | RGD:6480464 | CTD | |
| G | MYO7A | myosin VIIA |
|
decreases expression | ISO | 11 | 76,839,310 | 76,926,286 | RGD:6480464 | CTD | |
| G | MYOCD | myocardin |
|
increases expression | ISO | 17 | 12,569,207 | 12,670,651 | RGD:6480464 | CTD | |
| G | MYOM1 | myomesin 1 |
|
multiple interactions | ISO | 18 | 3,066,805 | 3,220,106 | RGD:6480464 | CTD | |
| G | MYOM1 | myomesin 1 |
|
multiple interactions | ISO | 18 | 3,066,805 | 3,220,106 | RGD:6480464 | CTD | |
| G | MYOM1 | myomesin 1 |
|
increases expression | ISO | 18 | 3,066,805 | 3,220,106 | RGD:6480464 | CTD | |
| G | MYOM2 | myomesin 2 |
|
increases expression | ISO | 8 | 1,993,158 | 2,093,380 | RGD:6480464 | CTD | |
| G | MYOT | myotilin |
|
multiple interactions | ISO | 5 | 137,203,545 | 137,223,540 | RGD:6480464 | CTD | |
| G | MYOT | myotilin |
|
increases expression | ISO | 5 | 137,203,545 | 137,223,540 | RGD:6480464 | CTD | |
| G | MYRIP | myosin VIIA and Rab interacting protein |
|
multiple interactions | EXP | 3 | 39,851,303 | 40,301,812 | RGD:6480464 | CTD | |
| G | N4BP2L1 | NEDD4 binding protein 2-like 1 |
|
multiple interactions | EXP | 13 | 32,974,860 | 33,002,315 | RGD:6480464 | CTD | |
| G | N4BP2L1 | NEDD4 binding protein 2-like 1 |
|
multiple interactions | ISO | 13 | 32,974,860 | 33,002,315 | RGD:6480464 | CTD | |
| G | N4BP2L1 | NEDD4 binding protein 2-like 1 |
|
increases expression | ISO | 13 | 32,974,860 | 33,002,315 | RGD:6480464 | CTD | |
| G | N6AMT1 | N-6 adenine-specific DNA methyltransferase 1 (putative) |
|
increases expression | ISO | 21 | 30,244,513 | 30,257,695 | RGD:6480464 | CTD | |
| G | NAA35 | N(alpha)-acetyltransferase 35, NatC auxiliary subunit |
|
decreases expression | ISO | 9 | 88,556,057 | 88,637,217 | RGD:6480464 | CTD | |
| G | NAA35 | N(alpha)-acetyltransferase 35, NatC auxiliary subunit |
|
increases expression | ISO | 9 | 88,556,057 | 88,637,217 | RGD:6480464 | CTD | |
| G | NAA38 | N(alpha)-acetyltransferase 38, NatC auxiliary subunit |
|
increases expression | ISO | 7 | 117,824,086 | 117,844,093 | RGD:6480464 | CTD | |
| G | NAB1 | NGFI-A binding protein 1 (EGR1 binding protein 1) |
|
increases expression | ISO | 2 | 191,513,848 | 191,557,492 | RGD:6480464 | CTD | |
| G | NAB2 | NGFI-A binding protein 2 (EGR1 binding protein 2) |
|
decreases expression | ISO | 12 | 57,482,677 | 57,489,259 | RGD:6480464 | CTD | |
| G | NAB2 | NGFI-A binding protein 2 (EGR1 binding protein 2) |
|
multiple interactions | ISO | 12 | 57,482,677 | 57,489,259 | RGD:6480464 | CTD | |
| G | NACC2 | NACC family member 2, BEN and BTB (POZ) domain containing |
|
multiple interactions | EXP | 9 | 138,898,383 | 138,987,131 | RGD:6480464 | CTD | |
| G | NADK | NAD kinase |
|
increases expression | ISO | 1 | 1,682,671 | 1,711,508 | RGD:6480464 | CTD | |
| G | NAGA | N-acetylgalactosaminidase, alpha- |
|
multiple interactions | EXP | 22 | 42,454,338 | 42,466,846 | RGD:6480464 | CTD | |
| G | NAGA | N-acetylgalactosaminidase, alpha- |
|
decreases expression | ISO | 22 | 42,454,338 | 42,466,846 | RGD:6480464 | CTD | |
| G | NAGK | N-acetylglucosamine kinase |
|
multiple interactions | EXP | 2 | 71,295,408 | 71,305,998 | RGD:6480464 | CTD | |
| G | NAGK | N-acetylglucosamine kinase |
|
increases expression | ISO | 2 | 71,295,408 | 71,305,998 | RGD:6480464 | CTD | |
| G | NANOS1 | nanos homolog 1 (Drosophila) |
|
multiple interactions | EXP | 10 | 120,789,228 | 120,793,854 | RGD:6480464 | CTD | |
| G | NANS | N-acetylneuraminic acid synthase |
|
decreases expression | ISO | 9 | 100,818,959 | 100,845,365 | RGD:6480464 | CTD | |
| G | NAP1L1 | nucleosome assembly protein 1-like 1 |
|
increases expression | ISO | 12 | 76,438,672 | 76,478,738 | RGD:6480464 | CTD | |
| G | NAP1L1 | nucleosome assembly protein 1-like 1 |
|
decreases expression | ISO | 12 | 76,438,672 | 76,478,738 | RGD:6480464 | CTD | |
| G | NAP1L1 | nucleosome assembly protein 1-like 1 |
|
multiple interactions | ISO | 12 | 76,438,672 | 76,478,738 | RGD:6480464 | CTD | |
| G | NAP1L1 | nucleosome assembly protein 1-like 1 |
|
affects expression | ISO | 12 | 76,438,672 | 76,478,738 | RGD:6480464 | CTD | |
| G | NAP1L1 | nucleosome assembly protein 1-like 1 |
|
increases expression | ISO | 12 | 76,438,672 | 76,478,738 | RGD:6480464 | CTD | |
| G | NCEH1 | neutral cholesterol ester hydrolase 1 |
|
increases expression | ISO | 3 | 172,348,435 | 172,429,008 | RGD:6480464 | CTD | |
| G | NCEH1 | neutral cholesterol ester hydrolase 1 |
|
multiple interactions | ISO | 3 | 172,348,435 | 172,429,008 | RGD:6480464 | CTD | |
| G | NDUFS5 | NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase) |
|
affects expression | ISO | 1 | 39,491,967 | 39,500,308 | RGD:6480464 | CTD | |
| G | NEB | nebulin |
|
multiple interactions | ISO | 2 | 152,341,853 | 152,591,001 | RGD:6480464 | CTD | |
| G | NEB | nebulin |
|
decreases expression | ISO | 2 | 152,341,853 | 152,591,001 | RGD:6480464 | CTD | |
| G | NECAB2 | N-terminal EF-hand calcium binding protein 2 |
|
multiple interactions | ISO | 16 | 84,002,237 | 84,036,379 | RGD:6480464 | CTD | |
| G | NECAP2 | NECAP endocytosis associated 2 |
|
multiple interactions | EXP | 1 | 16,767,167 | 16,786,585 | RGD:6480464 | CTD | |
| G | NECAP2 | NECAP endocytosis associated 2 |
|
multiple interactions | ISO | 1 | 16,767,167 | 16,786,585 | RGD:6480464 | CTD | |
| G | NEDD4 | neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase |
|
decreases expression | ISO | 15 | 56,119,120 | 56,285,835 | RGD:6480464 | CTD | |
| G | NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
|
increases expression | ISO | 18 | 55,711,610 | 56,068,772 | RGD:6480464 | CTD | |
| G | NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 |
|
multiple interactions | ISO | 6 | 11,183,531 | 11,382,581 | RGD:6480464 | CTD | |
| G | NEFH | neurofilament, heavy polypeptide |
|
multiple interactions | EXP | 22 | 29,876,181 | 29,887,279 | RGD:6480464 | CTD | |
| G | NEK1 | NIMA-related kinase 1 |
|
multiple interactions | ISO | 4 | 170,314,421 | 170,533,778 | RGD:6480464 | CTD | |
| G | NEK1 | NIMA-related kinase 1 |
|
increases expression | ISO | 4 | 170,314,421 | 170,533,778 | RGD:6480464 | CTD | |
| G | NEK2 | NIMA-related kinase 2 |
|
increases expression | ISO | 1 | 211,831,598 | 211,848,972 | RGD:6480464 | CTD | |
| G | NEK2 | NIMA-related kinase 2 |
|
multiple interactions | ISO | 1 | 211,831,598 | 211,848,972 | RGD:6480464 | CTD | |
| G | NEK3 | NIMA-related kinase 3 |
|
increases expression | ISO | 13 | 52,706,779 | 52,733,996 | RGD:6480464 | CTD | |
| G | NEK6 | NIMA-related kinase 6 |
|
multiple interactions | EXP | 9 | 127,019,885 | 127,114,721 | RGD:6480464 | CTD | |
| G | NEK6 | NIMA-related kinase 6 |
|
decreases expression | ISO | 9 | 127,019,885 | 127,114,721 | RGD:6480464 | CTD | |
| G | NEK7 | NIMA-related kinase 7 |
|
increases expression | ISO | 1 | 198,126,108 | 198,291,550 | RGD:6480464 | CTD | |
| G | NEK8 | NIMA-related kinase 8 |
|
multiple interactions | ISO | 17 | 27,055,832 | 27,069,784 | RGD:6480464 | CTD | |
| G | NENF | neudesin neurotrophic factor |
|
increases expression | ISO | 1 | 212,606,229 | 212,619,721 | RGD:6480464 | CTD | |
| G | NET1 | neuroepithelial cell transforming 1 |
|
increases expression | ISO | 10 | 5,454,514 | 5,501,019 | RGD:6480464 | CTD | |
| G | NETO2 | neuropilin (NRP) and tolloid (TLL)-like 2 |
|
increases expression | ISO | 16 | 47,115,431 | 47,177,936 | RGD:6480464 | CTD | |
| G | NEU2 | sialidase 2 (cytosolic sialidase) |
|
increases expression | ISO | 2 | 233,897,382 | 233,899,767 | RGD:6480464 | CTD | |
| G | NEU2 | sialidase 2 (cytosolic sialidase) |
|
affects expression | ISO | 2 | 233,897,382 | 233,899,767 | RGD:6480464 | CTD | |
| G | NEU3 | sialidase 3 (membrane sialidase) |
|
multiple interactions | ISO | 11 | 74,699,950 | 74,718,743 | RGD:6480464 | CTD | |
| G | NEURL | neuralized homolog (Drosophila) |
|
decreases expression | ISO | 10 | 105,253,735 | 105,352,309 | RGD:6480464 | CTD | |
| G | NEURL | neuralized homolog (Drosophila) |
|
multiple interactions | ISO | 10 | 105,253,735 | 105,352,309 | RGD:6480464 | CTD | |
| G | NEURL2 | neuralized homolog 2 (Drosophila) |
|
affects expression | ISO | 20 | 44,517,267 | 44,519,901 | RGD:6480464 | CTD | |
| G | NEURL2 | neuralized homolog 2 (Drosophila) |
|
increases expression | ISO | 20 | 44,517,267 | 44,519,901 | RGD:6480464 | CTD | |
| G | NEURL2 | neuralized homolog 2 (Drosophila) |
|
multiple interactions | ISO | 20 | 44,517,267 | 44,519,901 | RGD:6480464 | CTD | |
| G | NFAT5 | nuclear factor of activated T-cells 5, tonicity-responsive |
|
decreases expression | ISO | 16 | 69,599,869 | 69,738,569 | RGD:6480464 | CTD | |
| G | NFAT5 | nuclear factor of activated T-cells 5, tonicity-responsive |
|
multiple interactions | ISO | 16 | 69,599,869 | 69,738,569 | RGD:6480464 | CTD | |
| G | NFATC2 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
|
multiple interactions | ISO | 20 | 50,003,494 | 50,179,370 | RGD:6480464 | CTD | |
| G | NFATC2 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
|
decreases expression | ISO | 20 | 50,003,494 | 50,179,370 | RGD:6480464 | CTD | |
| G | NFE2L1 | nuclear factor (erythroid-derived 2)-like 1 |
|
increases expression | ISO | 17 | 46,125,686 | 46,138,907 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
decreases expression | ISO | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
increases expression | ISO | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NFIA | nuclear factor I/A |
|
increases expression | ISO | 1 | 61,542,946 | 61,928,460 | RGD:6480464 | CTD | |
| G | NFIB | nuclear factor I/B |
|
decreases expression | ISO | 9 | 14,081,842 | 14,398,982 | RGD:6480464 | CTD | |
| G | NFIL3 | nuclear factor, interleukin 3 regulated |
|
decreases expression | ISO | 9 | 94,171,327 | 94,186,144 | RGD:6480464 | CTD | |
| G | NFIL3 | nuclear factor, interleukin 3 regulated |
|
increases expression | ISO | 9 | 94,171,327 | 94,186,144 | RGD:6480464 | CTD | |
| G | NFIX | nuclear factor I/X (CCAAT-binding transcription factor) |
|
decreases expression | ISO | 19 | 13,106,584 | 13,209,610 | RGD:6480464 | CTD | |
| G | NFIX | nuclear factor I/X (CCAAT-binding transcription factor) |
|
multiple interactions | ISO | 19 | 13,106,584 | 13,209,610 | RGD:6480464 | CTD | |
| G | NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions | ISO | 4 | 103,422,486 | 103,538,459 | RGD:6480464 | CTD | |
| G | NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
decreases expression | ISO | 4 | 103,422,486 | 103,538,459 | RGD:6480464 | CTD | |
| G | NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions | ISO | 4 | 103,422,486 | 103,538,459 | RGD:6480464 | CTD | |
| G | NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
|
decreases expression | ISO | 10 | 104,153,867 | 104,162,286 | RGD:6480464 | CTD | |
| G | NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions | ISO | 14 | 35,870,716 | 35,873,960 | RGD:6480464 | CTD | |
| G | NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
decreases expression | ISO | 14 | 35,870,716 | 35,873,960 | RGD:6480464 | CTD | |
| G | NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases degradation | ISO | 14 | 35,870,716 | 35,873,960 | RGD:6480464 | CTD | |
| G | NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases expression | ISO | 14 | 35,870,716 | 35,873,960 | RGD:6480464 | CTD | |
| G | NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases expression | ISO | 14 | 35,870,716 | 35,873,960 | RGD:6480464 | CTD | |
| G | NOL11 | nucleolar protein 11 |
|
increases expression | ISO | 17 | 65,714,061 | 65,740,266 | RGD:6480464 | CTD | |
| G | NOL3 | nucleolar protein 3 (apoptosis repressor with CARD domain) |
|
increases expression | ISO | 16 | 67,204,405 | 67,209,643 | RGD:6480464 | CTD | |
| G | NOL3 | nucleolar protein 3 (apoptosis repressor with CARD domain) |
|
multiple interactions | ISO | 16 | 67,204,405 | 67,209,643 | RGD:6480464 | CTD | |
| G | NOL7 | nucleolar protein 7, 27kDa |
|
increases expression | ISO | 6 | 13,615,559 | 13,621,127 | RGD:6480464 | CTD | |
| G | NOLC1 | nucleolar and coiled-body phosphoprotein 1 |
|
increases expression | ISO | 10 | 103,911,933 | 103,923,627 | RGD:6480464 | CTD | |
| G | NOP16 | NOP16 nucleolar protein |
|
multiple interactions | ISO | 5 | 175,810,940 | 175,815,763 | RGD:6480464 | CTD | |
| G | NOS2 | nitric oxide synthase 2, inducible |
|
multiple interactions | ISO | 17 | 26,083,792 | 26,127,555 | RGD:6480464 | CTD | |
| G | NOS2 | nitric oxide synthase 2, inducible |
|
decreases expression | ISO | 17 | 26,083,792 | 26,127,555 | RGD:6480464 | CTD | |
| G | NOS2 | nitric oxide synthase 2, inducible |
|
decreases expression | ISO | 17 | 26,083,792 | 26,127,555 | RGD:6480464 | CTD | |
| G | NOS3 | nitric oxide synthase 3 (endothelial cell) |
|
multiple interactions | ISO | 7 | 150,688,144 | 150,711,687 | RGD:6480464 | CTD | |
| G | NOSTRIN | nitric oxide synthase trafficker |
|
multiple interactions | EXP | 2 | 169,643,049 | 169,721,849 | RGD:6480464 | CTD | |
| G | NOTCH1 | notch 1 |
|
increases expression | ISO | 9 | 139,388,896 | 139,440,238 | RGD:6480464 | CTD | |
| G | NOTCH2 | notch 2 |
|
decreases expression | ISO | 1 | 120,454,176 | 120,612,317 | RGD:6480464 | CTD | |
| G | NOVA1 | neuro-oncological ventral antigen 1 |
|
increases expression | ISO | 14 | 26,915,089 | 27,066,960 | RGD:6480464 | CTD | |
| G | NOX4 | NADPH oxidase 4 |
|
multiple interactions | ISO | 11 | 89,057,521 | 89,322,779 | RGD:6480464 | CTD | |
| G | NOX4 | NADPH oxidase 4 |
|
decreases expression | ISO | 11 | 89,057,521 | 89,322,779 | RGD:6480464 | CTD | |
| G | NOX4 | NADPH oxidase 4 |
|
decreases expression | ISO | 11 | 89,057,521 | 89,322,779 | RGD:6480464 | CTD | |
| G | NPAS2 | neuronal PAS domain protein 2 |
|
multiple interactions | EXP | 2 | 101,436,613 | 101,613,287 | RGD:6480464 | CTD | |
| G | NPC1 | Niemann-Pick disease, type C1 |
|
decreases expression | ISO | 18 | 21,111,463 | 21,166,581 | RGD:6480464 | CTD | |
| G | NPC1 | Niemann-Pick disease, type C1 |
|
multiple interactions | EXP | 18 | 21,111,463 | 21,166,581 | RGD:6480464 | CTD | |
| G | NPDC1 | neural proliferation, differentiation and control, 1 |
|
decreases expression | ISO | 9 | 139,933,909 | 139,940,676 | RGD:6480464 | CTD | |
| G | NPHP4 | nephronophthisis 4 |
|
multiple interactions | ISO | 1 | 5,922,870 | 6,052,533 | RGD:6480464 | CTD | |
| G | NPHS1 | nephrosis 1, congenital, Finnish type (nephrin) |
|
multiple interactions | EXP | 19 | 36,316,274 | 36,342,895 | RGD:6480464 | CTD | |
| G | NPHS1 | nephrosis 1, congenital, Finnish type (nephrin) |
|
increases expression | EXP | 19 | 36,316,274 | 36,342,895 | RGD:6480464 | CTD | |
| G | NPHS1 | nephrosis 1, congenital, Finnish type (nephrin) |
|
increases stability | EXP | 19 | 36,316,274 | 36,342,895 | RGD:6480464 | CTD | |
| G | NPHS2 | nephrosis 2, idiopathic, steroid-resistant (podocin) |
|
multiple interactions | EXP | 1 | 179,519,674 | 179,545,084 | RGD:6480464 | CTD | |
| G | NPL | N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase) |
|
decreases expression | ISO | 1 | 182,758,584 | 182,799,519 | RGD:6480464 | CTD | |
| G | NPM1 | nucleophosmin (nucleolar phosphoprotein B23, numatrin) |
|
increases expression | ISO | 5 | 170,814,708 | 170,837,888 | RGD:6480464 | CTD | |
| G | NPNT | nephronectin |
|
increases expression | ISO | 4 | 106,816,597 | 106,892,828 | RGD:6480464 | CTD | |
| G | NPPA | natriuretic peptide A |
|
multiple interactions | ISO | 1 | 11,905,766 | 11,907,840 | RGD:6480464 | CTD | |
| G | NPPA | natriuretic peptide A |
|
increases expression | ISO | 1 | 11,905,766 | 11,907,840 | RGD:6480464 | CTD | |
| G | NPPB | natriuretic peptide B |
|
multiple interactions | ISO | 1 | 11,917,521 | 11,918,992 | RGD:6480464 | CTD | |
| G | NPPB | natriuretic peptide B |
|
increases expression | ISO | 1 | 11,917,521 | 11,918,992 | RGD:6480464 | CTD | |
| G | NPR1 | natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) |
|
multiple interactions | EXP | 1 | 153,651,164 | 153,666,468 | RGD:6480464 | CTD | |
| G | NPR2 | natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B) |
|
multiple interactions | EXP | 9 | 35,792,406 | 35,809,728 | RGD:6480464 | CTD | |
| G | NPSR1 | neuropeptide S receptor 1 |
|
multiple interactions | ISO | 7 | 34,697,897 | 34,917,944 | RGD:6480464 | CTD | |
| G | NPSR1 | neuropeptide S receptor 1 |
|
decreases expression | ISO | 7 | 34,697,897 | 34,917,944 | RGD:6480464 | CTD | |
| G | NPTN | neuroplastin |
|
increases expression | ISO | 15 | 73,852,344 | 73,925,753 | RGD:6480464 | CTD | |
| G | NPY | neuropeptide Y |
|
decreases expression | ISO | 7 | 24,323,807 | 24,331,484 | RGD:6480464 | CTD | |
| G | NPY | neuropeptide Y |
|
decreases expression | ISO | 7 | 24,323,807 | 24,331,484 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
affects expression | ISO | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
increases expression | ISO | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
decreases expression | ISO | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions | ISO | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
increases expression | ISO | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NQO2 | NAD(P)H dehydrogenase, quinone 2 |
|
decreases expression | ISO | 6 | 3,000,067 | 3,019,994 | RGD:6480464 | CTD | |
| G | NR0B2 | nuclear receptor subfamily 0, group B, member 2 |
|
multiple interactions | EXP | 1 | 27,237,975 | 27,240,567 | RGD:6480464 | CTD | |
| G | NR0B2 | nuclear receptor subfamily 0, group B, member 2 |
|
multiple interactions | ISO | 1 | 27,237,975 | 27,240,567 | RGD:6480464 | CTD | |
| G | NR0B2 | nuclear receptor subfamily 0, group B, member 2 |
|
increases expression | ISO | 1 | 27,237,975 | 27,240,567 | RGD:6480464 | CTD | |
| G | NR0B2 | nuclear receptor subfamily 0, group B, member 2 |
|
multiple interactions | ISO | 1 | 27,237,975 | 27,240,567 | RGD:6480464 | CTD | |
| G | NSMF | NMDA receptor synaptonuclear signaling and neuronal migration factor |
|
decreases expression | ISO | 9 | 140,342,022 | 140,353,786 | RGD:6480464 | CTD | |
| G | NSMF | NMDA receptor synaptonuclear signaling and neuronal migration factor |
|
increases expression | ISO | 9 | 140,342,022 | 140,353,786 | RGD:6480464 | CTD | |
| G | NUBPL | nucleotide binding protein-like |
|
increases expression | ISO | 14 | 32,030,591 | 32,330,430 | RGD:6480464 | CTD | |
| G | NUBPL | nucleotide binding protein-like |
|
increases expression | ISO | 14 | 32,030,591 | 32,330,430 | RGD:6480464 | CTD | |
| G | NUCKS1 | nuclear casein kinase and cyclin-dependent kinase substrate 1 |
|
increases expression | ISO | 1 | 205,681,947 | 205,719,372 | RGD:6480464 | CTD | |
| G | NUDT11 | nudix (nucleoside diphosphate linked moiety X)-type motif 11 |
|
increases expression | ISO | X | 51,232,863 | 51,239,459 | RGD:6480464 | CTD | |
| G | NUDT12 | nudix (nucleoside diphosphate linked moiety X)-type motif 12 |
|
affects expression | ISO | 5 | 102,884,556 | 102,898,490 | RGD:6480464 | CTD | |
| G | NUDT12 | nudix (nucleoside diphosphate linked moiety X)-type motif 12 |
|
increases expression | ISO | 5 | 102,884,556 | 102,898,490 | RGD:6480464 | CTD | |
| G | NUDT12 | nudix (nucleoside diphosphate linked moiety X)-type motif 12 |
|
multiple interactions | ISO | 5 | 102,884,556 | 102,898,490 | RGD:6480464 | CTD | |
| G | NUDT13 | nudix (nucleoside diphosphate linked moiety X)-type motif 13 |
|
decreases expression | ISO | 10 | 74,870,210 | 74,891,581 | RGD:6480464 | CTD | |
| G | NUDT16L1 | nudix (nucleoside diphosphate linked moiety X)-type motif 16-like 1 |
|
multiple interactions | EXP | 16 | 4,743,694 | 4,745,860 | RGD:6480464 | CTD | |
| G | NUDT16L1 | nudix (nucleoside diphosphate linked moiety X)-type motif 16-like 1 |
|
decreases expression | ISO | 16 | 4,743,694 | 4,745,860 | RGD:6480464 | CTD | |
| G | NUDT18 | nudix (nucleoside diphosphate linked moiety X)-type motif 18 |
|
increases expression | ISO | 8 | 21,964,383 | 21,966,932 | RGD:6480464 | CTD | |
| G | NUDT18 | nudix (nucleoside diphosphate linked moiety X)-type motif 18 |
|
multiple interactions | EXP | 8 | 21,964,383 | 21,966,932 | RGD:6480464 | CTD | |
| G | NUDT19 | nudix (nucleoside diphosphate linked moiety X)-type motif 19 |
|
multiple interactions | ISO | 19 | 33,182,867 | 33,204,702 | RGD:6480464 | CTD | |
| G | NUDT22 | nudix (nucleoside diphosphate linked moiety X)-type motif 22 |
|
multiple interactions | ISO | 11 | 63,993,738 | 63,997,488 | RGD:6480464 | CTD | |
| G | NUDT4 | nudix (nucleoside diphosphate linked moiety X)-type motif 4 |
|
multiple interactions | EXP | 12 | 93,771,701 | 93,797,024 | RGD:6480464 | CTD | |
| G | NUDT4 | nudix (nucleoside diphosphate linked moiety X)-type motif 4 |
|
increases expression | ISO | 12 | 93,771,701 | 93,797,024 | RGD:6480464 | CTD | |
| G | NUDT5 | nudix (nucleoside diphosphate linked moiety X)-type motif 5 |
|
decreases expression | ISO | 10 | 12,209,573 | 12,238,143 | RGD:6480464 | CTD | |
| G | NUDT5 | nudix (nucleoside diphosphate linked moiety X)-type motif 5 |
|
affects expression | ISO | 10 | 12,209,573 | 12,238,143 | RGD:6480464 | CTD | |
| G | NUDT5 | nudix (nucleoside diphosphate linked moiety X)-type motif 5 |
|
increases expression | ISO | 10 | 12,209,573 | 12,238,143 | RGD:6480464 | CTD | |
| G | NUDT6 | nudix (nucleoside diphosphate linked moiety X)-type motif 6 |
|
increases expression | ISO | 4 | 123,813,799 | 123,844,159 | RGD:6480464 | CTD | |
| G | NUDT7 | nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
|
affects expression | ISO | 16 | 77,756,389 | 77,776,157 | RGD:6480464 | CTD | |
| G | NUDT7 | nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
|
decreases expression | ISO | 16 | 77,756,389 | 77,776,157 | RGD:6480464 | CTD | |
| G | NUDT7 | nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
|
increases expression | ISO | 16 | 77,756,389 | 77,776,157 | RGD:6480464 | CTD | |
| G | NUDT7 | nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
|
multiple interactions | ISO | 16 | 77,756,389 | 77,776,157 | RGD:6480464 | CTD | |
| G | NUDT7 | nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
|
multiple interactions | ISO | 16 | 77,756,389 | 77,776,157 | RGD:6480464 | CTD | |
| G | NUDT9 | nudix (nucleoside diphosphate linked moiety X)-type motif 9 |
|
increases expression | ISO | 4 | 88,343,728 | 88,380,606 | RGD:6480464 | CTD | |
| G | NUF2 | NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
|
multiple interactions | ISO | 1 | 163,291,723 | 163,325,553 | RGD:6480464 | CTD | |
| G | NUF2 | NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
|
increases expression | ISO | 1 | 163,291,723 | 163,325,553 | RGD:6480464 | CTD | |
| G | NUFIP2 | nuclear fragile X mental retardation protein interacting protein 2 |
|
decreases expression | ISO | 17 | 27,582,854 | 27,621,166 | RGD:6480464 | CTD | |
| G | NUMA1 | nuclear mitotic apparatus protein 1 |
|
decreases expression | ISO | 11 | 71,713,911 | 71,791,573 | RGD:6480464 | CTD | |
| G | NUMBL | numb homolog (Drosophila)-like |
|
multiple interactions | EXP | 19 | 41,171,810 | 41,196,556 | RGD:6480464 | CTD | |
| G | NUMBL | numb homolog (Drosophila)-like |
|
multiple interactions | ISO | 19 | 41,171,810 | 41,196,556 | RGD:6480464 | CTD | |
| G | NUP153 | nucleoporin 153kDa |
|
decreases expression | ISO | 6 | 17,615,269 | 17,706,818 | RGD:6480464 | CTD | |
| G | NUP160 | nucleoporin 160kDa |
|
decreases expression | ISO | 11 | 47,799,670 | 47,870,057 | RGD:6480464 | CTD | |
| G | NUP210 | nucleoporin 210kDa |
|
increases expression | ISO | 3 | 13,357,737 | 13,461,809 | RGD:6480464 | CTD | |
| G | NUP210 | nucleoporin 210kDa |
|
decreases expression | ISO | 3 | 13,357,737 | 13,461,809 | RGD:6480464 | CTD | |
| G | NUP210 | nucleoporin 210kDa |
|
multiple interactions | ISO | 3 | 13,357,737 | 13,461,809 | RGD:6480464 | CTD | |
| G | NUP214 | nucleoporin 214kDa |
|
multiple interactions | EXP | 9 | 134,000,981 | 134,109,091 | RGD:6480464 | CTD | |
| G | NUP37 | nucleoporin 37kDa |
|
decreases expression | ISO | 12 | 102,467,970 | 102,512,361 | RGD:6480464 | CTD | |
| G | NUP54 | nucleoporin 54kDa |
|
decreases expression | ISO | 4 | 77,035,817 | 77,069,655 | RGD:6480464 | CTD | |
| G | NUP62 | nucleoporin 62kDa |
|
multiple interactions | EXP | 19 | 50,410,082 | 50,432,988 | RGD:6480464 | CTD | |
| G | NUP62 | nucleoporin 62kDa |
|
decreases expression | ISO | 19 | 50,410,082 | 50,432,988 | RGD:6480464 | CTD | |
| G | NUP62 | nucleoporin 62kDa |
|
increases expression | ISO | 19 | 50,410,082 | 50,432,988 | RGD:6480464 | CTD | |
| G | NUP88 | nucleoporin 88kDa |
|
multiple interactions | EXP | 17 | 5,289,346 | 5,323,059 | RGD:6480464 | CTD | |
| G | NUP93 | nucleoporin 93kDa |
|
increases expression | ISO | 16 | 56,764,017 | 56,878,862 | RGD:6480464 | CTD | |
| G | NUPR1 | nuclear protein, transcriptional regulator, 1 |
|
multiple interactions | ISO | 16 | 28,548,662 | 28,550,495 | RGD:6480464 | CTD | |
| G | NUPR1 | nuclear protein, transcriptional regulator, 1 |
|
decreases expression | ISO | 16 | 28,548,662 | 28,550,495 | RGD:6480464 | CTD | |
| G | NUPR1 | nuclear protein, transcriptional regulator, 1 |
|
increases expression | ISO | 16 | 28,548,662 | 28,550,495 | RGD:6480464 | CTD | |
| G | OBP2A | odorant binding protein 2A |
|
multiple interactions | ISO | 9 | 138,437,985 | 138,441,815 | RGD:6480464 | CTD | |
| G | OBP2B | odorant binding protein 2B |
|
multiple interactions | ISO | 9 | 136,080,666 | 136,084,628 | RGD:6480464 | CTD | |
| G | OLIG1 | oligodendrocyte transcription factor 1 |
|
decreases expression | ISO | 21 | 34,442,450 | 34,444,728 | RGD:6480464 | CTD | |
| G | OLIG1 | oligodendrocyte transcription factor 1 |
|
multiple interactions | ISO | 21 | 34,442,450 | 34,444,728 | RGD:6480464 | CTD | |
| G | OLIG1 | oligodendrocyte transcription factor 1 |
|
increases expression | ISO | 21 | 34,442,450 | 34,444,728 | RGD:6480464 | CTD | |
| G | OMA1 | OMA1 zinc metallopeptidase homolog (S. cerevisiae) |
|
increases expression | ISO | 1 | 58,946,391 | 59,012,446 | RGD:6480464 | CTD | |
| G | OMD | osteomodulin |
|
decreases expression | ISO | 9 | 95,176,527 | 95,186,836 | RGD:6480464 | CTD | |
| G | OMD | osteomodulin |
|
multiple interactions | ISO | 9 | 95,176,527 | 95,186,836 | RGD:6480464 | CTD | |
| G | ONECUT1 | one cut homeobox 1 |
|
decreases expression | ISO | 15 | 53,049,353 | 53,082,209 | RGD:6480464 | CTD | |
| G | ONECUT1 | one cut homeobox 1 |
|
multiple interactions | ISO | 15 | 53,049,353 | 53,082,209 | RGD:6480464 | CTD | |
| G | ONECUT2 | one cut homeobox 2 |
|
multiple interactions | ISO | 18 | 55,102,917 | 55,158,530 | RGD:6480464 | CTD | |
| G | OOEP | oocyte expressed protein |
|
multiple interactions | EXP | 6 | 74,078,278 | 74,079,515 | RGD:6480464 | CTD | |
| G | OPALIN | oligodendrocytic myelin paranodal and inner loop protein |
|
increases expression | ISO | 10 | 98,102,973 | 98,119,092 | RGD:6480464 | CTD | |
| G | OPHN1 | oligophrenin 1 |
|
increases expression | ISO | X | 67,262,186 | 67,653,299 | RGD:6480464 | CTD | |
| G | OPLAH | 5-oxoprolinase (ATP-hydrolysing) |
|
increases expression | ISO | 8 | 145,106,167 | 145,115,584 | RGD:6480464 | CTD | |
| G | OPLAH | 5-oxoprolinase (ATP-hydrolysing) |
|
multiple interactions | ISO | 8 | 145,106,167 | 145,115,584 | RGD:6480464 | CTD | |
| G | OR2L13 | olfactory receptor, family 2, subfamily L, member 13 |
|
affects expression | ISO | 1 | 248,100,493 | 248,264,224 | RGD:6480464 | CTD | |
| G | OR4C3 | olfactory receptor, family 4, subfamily C, member 3 |
|
decreases expression | ISO | 11 | 48,346,493 | 48,347,482 | RGD:6480464 | CTD | |
| G | OR51E2 | olfactory receptor, family 51, subfamily E, member 2 |
|
decreases expression | ISO | 11 | 4,701,401 | 4,719,076 | RGD:6480464 | CTD | |
| G | OR51E2 | olfactory receptor, family 51, subfamily E, member 2 |
|
affects expression | ISO | 11 | 4,701,401 | 4,719,076 | RGD:6480464 | CTD | |
| G | OR5T2 | olfactory receptor, family 5, subfamily T, member 2 |
|
decreases expression | ISO | 11 | 55,999,582 | 56,000,661 | RGD:6480464 | CTD | |
| G | OR8B1P | olfactory receptor, family 8, subfamily B, member 1 pseudogene |
|
decreases expression | ISO | 11 | 124,235,315 | 124,236,287 | RGD:6480464 | CTD | |
| G | OR8B1P | olfactory receptor, family 8, subfamily B, member 1 pseudogene |
|
multiple interactions | ISO | 11 | 124,235,315 | 124,236,287 | RGD:6480464 | CTD | |
| G | OR8G5 | olfactory receptor, family 8, subfamily G, member 5 |
|
multiple interactions | ISO | 11 | 124,134,723 | 124,135,763 | RGD:6480464 | CTD | |
| G | OR8G5 | olfactory receptor, family 8, subfamily G, member 5 |
|
decreases expression | ISO | 11 | 124,134,723 | 124,135,763 | RGD:6480464 | CTD | |
| G | PCCA | propionyl CoA carboxylase, alpha polypeptide |
|
increases expression | ISO | 13 | 100,741,269 | 101,182,691 | RGD:6480464 | CTD | |
| G | PCMTD2 | protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2 |
|
decreases expression | ISO | 20 | 62,887,048 | 62,907,579 | RGD:6480464 | CTD | |
| G | PDHX | pyruvate dehydrogenase complex, component X |
|
increases expression | ISO | 11 | 34,937,677 | 35,017,675 | RGD:6480464 | CTD | |
| G | PEX19 | peroxisomal biogenesis factor 19 |
|
affects expression | ISO | 1 | 160,246,599 | 160,254,941 | RGD:6480464 | CTD | |
| G | PIGP | phosphatidylinositol glycan anchor biosynthesis, class P |
|
affects expression | ISO | 21 | 38,437,664 | 38,445,458 | RGD:6480464 | CTD | |
| G | RAB5A | RAB5A, member RAS oncogene family |
|
increases expression | ISO | 3 | 19,988,572 | 20,026,667 | RGD:6480464 | CTD | |
| G | RAPH1 | Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 |
|
multiple interactions | ISO | 2 | 204,298,538 | 204,400,058 | RGD:6480464 | CTD | |
| G | RASA3 | RAS p21 protein activator 3 |
|
decreases expression | ISO | 13 | 114,747,194 | 114,898,095 | RGD:6480464 | CTD | |
| G | RASA3 | RAS p21 protein activator 3 |
|
multiple interactions | ISO | 13 | 114,747,194 | 114,898,095 | RGD:6480464 | CTD | |
| G | RBFOX2 | RNA binding protein, fox-1 homolog (C. elegans) 2 |
|
multiple interactions | EXP | 22 | 36,134,783 | 36,424,585 | RGD:6480464 | CTD | |
| G | RDH16 | retinol dehydrogenase 16 (all-trans) |
|
increases expression | ISO | 12 | 57,345,215 | 57,351,418 | RGD:6480464 | CTD | |
| G | RDH16 | retinol dehydrogenase 16 (all-trans) |
|
multiple interactions | ISO | 12 | 57,345,215 | 57,351,418 | RGD:6480464 | CTD | |
| G | REG3G | regenerating islet-derived 3 gamma |
|
decreases expression | ISO | 2 | 79,252,812 | 79,255,630 | RGD:6480464 | CTD | |
| G | REG3G | regenerating islet-derived 3 gamma |
|
increases expression | ISO | 2 | 79,252,812 | 79,255,630 | RGD:6480464 | CTD | |
| G | RPL14 | ribosomal protein L14 |
|
increases expression | ISO | 3 | 40,498,783 | 40,503,863 | RGD:6480464 | CTD | |
| G | RPL17 | ribosomal protein L17 |
|
affects expression | ISO | 18 | 47,014,851 | 47,018,935 | RGD:6480464 | CTD | |
| G | RPL17 | ribosomal protein L17 |
|
increases expression | ISO | 18 | 47,014,851 | 47,018,935 | RGD:6480464 | CTD | |
| G | RPL7A | ribosomal protein L7a |
|
increases expression | ISO | 9 | 136,215,069 | 136,218,280 | RGD:6480464 | CTD | |
| G | RPS27L | ribosomal protein S27-like |
|
increases expression | ISO | 15 | 63,445,539 | 63,449,741 | RGD:6480464 | CTD | |
| G | RPS27L | ribosomal protein S27-like |
|
increases expression | ISO | 15 | 63,445,539 | 63,449,741 | RGD:6480464 | CTD | |
| G | SAA2 | serum amyloid A2 |
|
multiple interactions | ISO | 11 | 18,259,780 | 18,270,221 | RGD:6480464 | CTD | |
| G | SAA2 | serum amyloid A2 |
|
decreases expression | ISO | 11 | 18,259,780 | 18,270,221 | RGD:6480464 | CTD | |
| G | SAA2 | serum amyloid A2 |
|
multiple interactions | ISO | 11 | 18,259,780 | 18,270,221 | RGD:6480464 | CTD | |
| G | SAA2 | serum amyloid A2 |
|
multiple interactions | ISO | 11 | 18,259,780 | 18,270,221 | RGD:6480464 | CTD | |
| G | SAA2 | serum amyloid A2 |
|
multiple interactions | ISO | 11 | 18,259,780 | 18,270,221 | RGD:6480464 | CTD | |
| G | SAA2 | serum amyloid A2 |
|
multiple interactions | ISO | 11 | 18,259,780 | 18,270,221 | RGD:6480464 | CTD | |
| G | SAA2 | serum amyloid A2 |
|
decreases expression | ISO | 11 | 18,259,780 | 18,270,221 | RGD:6480464 | CTD | |
| G | SCAF8 | SR-related CTD-associated factor 8 |
|
increases expression | ISO | 6 | 155,054,512 | 155,155,194 | RGD:6480464 | CTD | |
| G | SIGLEC8 | sialic acid binding Ig-like lectin 8 |
|
decreases expression | ISO | 19 | 51,954,251 | 51,961,708 | RGD:6480464 | CTD | |
| G | SLC25A51 | solute carrier family 25, member 51 |
|
increases expression | ISO | 9 | 37,877,572 | 37,904,350 | RGD:6480464 | CTD | |
| G | SLC9B1 | solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1 |
|
increases expression | ISO | 4 | 103,806,205 | 103,940,896 | RGD:6480464 | CTD | |
| G | SLC9B1 | solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1 |
|
multiple interactions | ISO | 4 | 103,806,205 | 103,940,896 | RGD:6480464 | CTD | |
| G | SLCO1A2 | solute carrier organic anion transporter family, member 1A2 |
|
decreases expression | ISO | 12 | 21,417,534 | 21,548,371 | RGD:6480464 | CTD | |
| G | SPATA31D4 | SPATA31 subfamily D, member 4 |
|
increases expression | ISO | 9 | 84,543,343 | 84,549,913 | RGD:6480464 | CTD | |
| G | TGFBI | transforming growth factor, beta-induced, 68kDa |
|
affects expression | ISO | 5 | 135,364,584 | 135,399,507 | RGD:6480464 | CTD | |
| G | TGOLN2 | trans-golgi network protein 2 |
|
increases expression | ISO | 2 | 85,545,141 | 85,555,419 | RGD:6480464 | CTD | |
| G | TGOLN2 | trans-golgi network protein 2 |
|
increases expression | ISO | 2 | 85,545,141 | 85,555,419 | RGD:6480464 | CTD | |
| G | TGOLN2 | trans-golgi network protein 2 |
|
increases expression | ISO | 2 | 85,545,141 | 85,555,419 | RGD:6480464 | CTD | |
| G | TGOLN2 | trans-golgi network protein 2 |
|
multiple interactions | ISO | 2 | 85,545,141 | 85,555,419 | RGD:6480464 | CTD | |
| G | TMED7 | transmembrane emp24 protein transport domain containing 7 |
|
affects expression | ISO | 5 | 114,948,905 | 114,961,876 | RGD:6480464 | CTD | |
| G | TMEM254 | transmembrane protein 254 |
|
increases expression | ISO | 10 | 81,838,402 | 81,852,307 | RGD:6480464 | CTD | |
| G | TMEM61 | transmembrane protein 61 |
|
multiple interactions | ISO | 1 | 55,446,465 | 55,457,966 | RGD:6480464 | CTD | |
| G | TMX2 | thioredoxin-related transmembrane protein 2 |
|
increases expression | ISO | 11 | 57,479,995 | 57,508,445 | RGD:6480464 | CTD | |
| G | TPM3 | tropomyosin 3 |
|
decreases expression | ISO | 1 | 154,127,780 | 154,164,609 | RGD:6480464 | CTD | |
| G | TRIM6 | tripartite motif containing 6 |
|
multiple interactions | ISO | 11 | 5,617,331 | 5,634,188 | RGD:6480464 | CTD | |
| G | TRRAP | transformation/transcription domain-associated protein |
|
decreases expression | ISO | 7 | 98,476,113 | 98,610,866 | RGD:6480464 | CTD | |
| G | TUBGCP6 | tubulin, gamma complex associated protein 6 |
|
decreases expression | ISO | 22 | 50,656,118 | 50,683,400 | RGD:6480464 | CTD | |
| G | UGT1A9 | UDP glucuronosyltransferase 1 family, polypeptide A9 |
|
multiple interactions | ISO | 2 | 234,580,544 | 234,681,951 | RGD:6480464 | CTD | |
| G | UGT2B17 | UDP glucuronosyltransferase 2 family, polypeptide B17 |
|
multiple interactions | ISO | 4 | 69,402,902 | 69,434,245 | RGD:6480464 | CTD | |
| G | UGT2B17 | UDP glucuronosyltransferase 2 family, polypeptide B17 |
|
decreases expression | ISO | 4 | 69,402,902 | 69,434,245 | RGD:6480464 | CTD | |
| G | UGT2B28 | UDP glucuronosyltransferase 2 family, polypeptide B28 |
|
decreases expression | ISO | 4 | 70,146,217 | 70,160,768 | RGD:6480464 | CTD | |
| G | UQCR11 | ubiquinol-cytochrome c reductase, complex III subunit XI |
|
affects expression | ISO | 19 | 1,597,154 | 1,605,483 | RGD:6480464 | CTD | |
| G | UQCRH | ubiquinol-cytochrome c reductase hinge protein |
|
decreases expression | ISO | 1 | 46,769,380 | 46,782,448 | RGD:6480464 | CTD | |
| G | ZNF160 | zinc finger protein 160 |
|
increases expression | ISO | 19 | 53,569,867 | 53,606,687 | RGD:6480464 | CTD | |
| G | ZNF324 | zinc finger protein 324 |
|
decreases expression | ISO | 19 | 58,978,412 | 58,984,945 | RGD:6480464 | CTD | |
| G | ZNF519 | zinc finger protein 519 |
|
decreases expression | ISO | 18 | 14,075,989 | 14,132,489 | RGD:6480464 | CTD | |
| G | ZNF519 | zinc finger protein 519 |
|
increases expression | ISO | 18 | 14,075,989 | 14,132,489 | RGD:6480464 | CTD | |
| G | ZNF571 | zinc finger protein 571 |
|
increases expression | ISO | 19 | 38,055,155 | 38,085,673 | RGD:6480464 | CTD | |
| G | ZNF616 | zinc finger protein 616 |
|
decreases expression | ISO | 19 | 52,617,653 | 52,643,191 | RGD:6480464 | CTD | |
| G | ZNF624 | zinc finger protein 624 |
|
decreases expression | ISO | 17 | 16,524,048 | 16,557,167 | RGD:6480464 | CTD | |
Term paths to the root
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




browse the term